2011-2012 UCCCC Annual Report - The University of Chicago ...

2011 – 2012 Annual Report
DICINE

LAB TO LIFE
Pushing the Pace of
Personalized Medicine
The University of Chicago
Medicine Comprehensive Cancer
Center (UCCCC) is at the forefront
of personalized medicine, leading
the long battle against cancer.
We are raising the standards
of medical practice by using
genetic, social, and environmental
factors to predict cancer risk and
tailor individualized prevention
and treatment strategies for
our patients.
Across the continuum of
cancer care, from prevention to
survivorship, we are transforming
the future of medicine.

2011 – 2012 Annual Report
Focusing on the me in
MEDICINE

table of
contents
4

A Message from the Director 2
Transforming the Routine Practice of Medicine 4
Dennis’s Story 6
From Bench to Bedside 10
Expanding Our Reach 12
Planting the Seeds of Survivorship 14
Vincent’s Story 16
Reducing Cancer in our Community 20
Shaping the Future of Cancer Care 22
A Snapshot of Cancer Care 24
Steve’s Story 28
Focus on Colorectal Cancer 32
Enhancing Quality and Enabling Innovation through Philanthropy 35
Natachie’s Story 40
Our Members 44
Vital Statistics 48
Financial Report 50
2011 – 2012 Donors 52
Credits 66
planting the seeds of survivorship

“We are poised
to transform the
future of medicine
and reduce the
devastating effects
of cancer.”

A Message from the Director
At the University of Chicago Medicine Comprehensive
Cancer Center (UCCCC), we are committed to fighting
cancer from every angle.
Our world-class cancer research program elevates the
quality of patient care by offering an unmatched level of
expertise. With 210 renowned physicians and researchers,
we are harnessing the power of personalized medicine
to offer faster, safer, and more effective treatments.
Our multidisciplinary teams of experts are committed
to developing individualized treatment plans to provide
the best possible care for our patients.
We are proud of our tremendous accomplishments,
which reflect our mission to translate ground-breaking
research into new strategies to prevent and treat cancer.
Over the past year, we have expanded efforts to integrate
personalized genomic medicine into routine practice,
expanded our survivorship resources to support
patients, applied the latest innovations in imaging and
genomics to advance our understanding of cancer, and
constructed new facilities that extend the reach of our
comprehensive care, including our new flagship “hospital
for the future.”
The next five years will be pivotal as we embark on a
bold strategic plan that accelerates basic and clinical
research into personalized cancer care. Three major initiatives
will focus on prevention, treatment, and survivorship.
Through the creation of a large multiethnic cohort
of healthy individuals and those at high risk for cancer,
our researchers will gain new knowledge about how
to prevent cancer for at-risk populations. We are also
establishing a new consortium to enhance our efforts
to enroll patients in clinical studies to test the most
effective treatments and interventions available. Sophisticated
tools will be used to link biological and molecular
imaging data with clinical outcomes so that we may
determine the likelihood of treatment response. On a
broader scale, we are leading an initiative to examine
the psychosocial needs of our growing population of
cancer survivors, and to maximize the impact of our
healthcare resources.
The launching of these new initiatives would not be possible
without the steadfast support of our donors who
continue to devote their time and resources to cancer
research. We are grateful for their generosity which has
funded some of our most transformative discoveries.
Building on the UCCCC’s legacy of seminal research discoveries,
our proven leadership in personalized oncology,
and our commitment to delivering the highest quality
comprehensive care, we are poised to transform the
future of medicine and reduce the devastating effects
of cancer.
With heartfelt gratitude,
Michelle M. Le Beau, PhD
Arthur and Marian Edelstein Professor of Medicine
UCCCC Director
a message from the director
3

Transforming
the Routine
Practice
of Medicine
4

Customized treatment tailored to the individual patient
Personalized medicine takes into account the unique
environmental, social, and biological factors — including
genetics — of each patient to tailor disease prevention
and treatment strategies. Instead of the trial-and-error
and “one size fits all” approaches of the past, personalized
medicine provides safer and more effective
cancer treatment.
The UCCCC is a leader in personalized medicine because
of our unique strengths in pharmacogenomics research,
which predicts an individual’s response to medication
based on genetics. We have launched high-priority initiatives
to incorporate pharmacogenomics into cancer care,
including the creation of a Center for Personalized Therapeutics.
The Center’s flagship study, The 1200 Patients
Project, is using genetic information to help physicians
prescribe the most effective medications with the fewest
side effects. Peter O’Donnell, MD, assistant professor of
medicine, is leading the study and determining how customized
treatment can be efficiently incorporated into
routine medical care. The UCCCC also implements pharmacogenomics
into more clinical trials, for both adult
and pediatric patients, than any other medical center
and is already using genetics to guide clinical practice.
As a result, our physicians can make patient-specific
dose modifications and avoid therapies that may cause
serious side effects in some patients but not others.
The promise of personalized medicine is being pursued
across all fronts of cancer research at the UCCCC. Ralph
Weichselbaum, MD, chair and D.K. Ludwig Professor
of Radiation and Cellular Oncology, discovered a gene
signature that predicts the response of breast tumors
to radiation and chemotherapy. “If we knew who would
respond in advance, we could identify the best treatment
upfront,” said Dr. Weichselbaum. Researchers are testing
his findings in clinical trials, which may one day be used
to optimize breast cancer treatment.
Our researchers are actively exploring new strategies to
treat melanoma, known as one of the deadliest cancers.
Thomas Gajewski, MD, PhD, professor of medicine and
pathology, is an expert in immune therapy, which stimulates
the body’s own immune system to fight cancer
cells. He has found a biological signature in melanoma
that could potentially predict a patient’s response
to cancer vaccines. Based on his research and newly
approved drugs for melanoma that target specific
genetic mutations in the tumor, Dr. Gajewski predicts
that the standard of care for melanoma will soon involve
routine screening of tumors for specific biological
markers to guide treatment decisions.
The work of our experts in hematological malignancies,
including James Vardiman, MD, professor of pathology,
and Michelle M. Le Beau, PhD, UCCCC Director
and Arthur and Marian Edelstein Professor of Medicine,
changed how the World Health Organization now classifies
hematopoietic and lymphoid cancers based on
chromosomal abnormalities, informing the selection
of risk-adapted therapy. These and hundreds of other
research discoveries reveal our rich history in translating
research into more effective, personalized cancer care.
HEALTH
FACTORS
SOCIAL
FACTORS
GENETICS
TUMOR
BIOLOGY
MY CANCER
JOURNEY
PERSONAL
HEALTH
BELIEFS
ENVIRONMENT
LIFESTYLE
FACTORS
Detection of chromosomal abnormalities in a pediatric patient
with pre-B-cell acute lymphoblastic leukemia
Dr. Olufunmilayo Olopade and patient
transforming the routine practice of medicine
5

My name is Dennis.
I love working with my hands and
keeping busy.
I was diagnosed with melanoma in 1997.
Here I am now, still doing the things
I love, thanks to the expertise at
the UCCCC.
Dennis’s story
7

I’m a survivor.
What started out as a bleeding mole on Dennis Hahn’s
back in 1997 turned into a long and trying struggle with
melanoma. After many surgeries and treatments at
various hospitals over the years, the cancer continued
to metastasize. That is when his oncologist referred him
to the UCCCC, which offers many clinical trials and
personalized therapies for advanced melanoma.
The outlook for this aggressive skin cancer is usually
poor, but experts at the UCCCC were able to offer
Dennis investigational therapies that slowed his cancer
without slowing him down. In addition to testing water
meters for the city of Goshen, Indiana, the 59-year-old
“jack-of-all-trades” fills his free time with a vast array of
hobbies and projects, whether it’s entering his homemade
maple syrup and apple butter in county fairs or
building a primitive cabin practically by himself.
UCCCC investigators are making significant advances
in melanoma research. One major goal is to develop new
drugs that prevent tumors from evading the patient’s
immune system. In the past few years, two breakthrough
therapies for metastatic melanoma were approved by
the FDA — ipilimumab, an immune therapy targeted
against CTLA-4, a protein involved in regulating immune
response; and vemurafenib, an inhibitor of the B-Raf
enzyme, which is involved in melanoma cell growth.
UCCCC researchers contributed to the development
of both of these drugs.
At the UCCCC, Dennis has had access to these and other
novel therapies through clinical trials. As his doctors
learned about the genetic mutations of his cancer, they
adjusted his treatment accordingly. Based on the unique
features of his melanoma, they used a vaccine to target
proteins specific to his tumor, boosted his immune
response with ipilimumab, and targeted the tumor’s
mutant BRAF gene with vemurafenib.
“More than half of our patients have clinical benefit now
with these new therapies, which is extraordinary compared
to where we were a few years ago,” said Professor
of Medicine Thomas Gajewski, MD, PhD, who is treating
Dennis. “By figuring out the reason why the tumor

“My cancer care
team never
treated me like
just a body.
They actually
cared ABout ”
— Dennis Hahn
sometimes sneaks through and becomes resistant, we
are learning which new drugs to develop and combine.”
Now, Dennis sees Dr. Gajewski every six weeks and has
scans every three months to monitor his disease. He also
brings his nurses and doctors gifts, such as samples
of his maple syrup and handmade crafts, to show his
appreciation for their top-notch care.
Dennis and his wife of 38 years, Margaret, said the experience
has taught them to appreciate life and to remain
focused on what is most important. Despite his cancer
treatments, the couple enjoys a very active lifestyle and
are close with their nieces, nephews, and their families,
often taking them fishing and camping.
“Times aren’t always easy, but you can’t give up,” Dennis
said. “You should always have hope.”
Looking Forward...
Based on the success of ipilimumab, new antibodies
that target a cousin of CTLA-4, called PD-1, are being
tested in patients. Early results show that 30% of
melanoma patients are responding to this treatment.
Researchers are working to find therapeutic biomarkers,
to identify patients who will respond to these
new treatments, so that physicians can more effectively
design personalized treatment plans.
Dennis’s story
9

from bench to bedside
Groundbreaking research fuels the development of
customized therapies to combat cancer.
The UCCCC capitalizes on the collective expertise of
its world-renowned researchers who are dedicated to
understanding all facets of cancer. Basic scientists and
clinical researchers work together to bridge scientific
disciplines and foster translational research, quickly
advancing laboratory discoveries into the clinic. These
discoveries translate to more effective, personalized
comprehensive cancer care, addressing risk, prevention,
diagnosis, treatment, and survivorship. The following
research studies illustrate how the UCCCC is pushing
the pace of personalized medicine to improve the
lives of all cancer patients.
Kenan Onel, MD, PhD
Associate Professor of Pediatrics
GENETIC VARIATIONS
FORETELL SECOND
CANCERS
Researchers can now
predict which women are
most likely to develop
second cancers resulting
from radiation therapy
years after treatment for
Hodgkin lymphoma.
Kenan Onel, MD, PhD,
associate professor of
pediatrics, found two genetic variants that were significantly
associated with increased cancer risk in Hodgkin
lymphoma survivors who had been treated with radiation
during childhood. These findings will allow clinicians
to better identify children who are most susceptible
to radiation-induced cancers and potentially modify
their care to prevent this disease. (Best et al., Nat Med
17:941-3, 2011)
This work was supported in part by the National Institutes of Health, the
Department of Defense, and the American Cancer Society-Illinois Division.
M. Eileen Dolan, PhD
Professor of Medicine
PREDICTING
RESPONSE TO
CHEMOTHERAPY
M. Eileen Dolan, PhD,
professor of medicine,
developed a cell-based
approach to identify
which patients with ovarian
cancer will respond
poorly to chemotherapy.
She discovered 18 genetic
markers that predicted
treatment outcome in nearly 400 patients with ovarian
cancer. These markers will help identify patients at risk
for not responding to certain therapies, and allow clinicians
to personalize treatment and improve outcomes
by administering alternative chemotherapy. (Huang
et al., Clin Cancer Res 17:5490-500, 2011)
This work was supported by the National Institute of General Medical Sciences,
the National Cancer Institute, and the National Heart Lung and Blood
Institute of the National Institutes of Health; the University of Chicago Comprehensive
Cancer Center Support grant; and the University of Chicago
Breast Cancer SPORE.
Stephen Kron, MD, PhD
Professor of Molecular Genetics
and Cell Biology
DISSECTING
RADIATION
RESPONSE
Stephen Kron, MD, PhD,
professor of molecular
genetics and cell biology,
is leading a collaboration
with Ralph Weichselbaum,
MD, D.K. Ludwig Professor
of Radiation and Cellular
Oncology, to understand
how radiation affects
cancer cells within growing tumors. Although radiation
is widely used to treat cancer, tumors often grow back.
Combined with techniques in molecular biology, Drs.
Kron and Weichselbaum apply advanced imaging and
irradiation tools to induce DNA damage and follow its
repair in mice. They have discovered that the benefits
of radiation therapy can be enhanced by non-toxic
drugs that block DNA repair and age cancer cells, and
that accumulation of aged cells appears to promote an
immune response against tumors. Confirming the roles
of cancer cell aging and immune activation in the success
of radiation treatment may lead to clinical studies to
test these drugs in patients within the next several years.
This work is being supported by the National Cancer Institute of the National
Institutes of Health and the Ludwig Center for Metastasis Research.
Aytekin Oto, MD
Professor of Radiology and Surgery
NEW APPROACH
FOR TREATING
PROSTATE CANCER
Current treatment options
for prostate cancer,
including radical prostatectomy
and radiation
therapy, are associated
with complications, such
as incontinence and
impotence, which
decrease quality of life.
Aytekin Oto, MD, professor of radiology and surgery,
successfully completed a Phase I trial demonstrating the
feasibility and safety of a new treatment approach —
MRI-guided focal laser ablation of prostate cancer. As
a result, Dr. Oto was awarded NIH funding to conduct
a Phase II trial in collaboration with Scott Eggener, MD,
assistant professor of surgery, to further evaluate the
efficacy of this new, minimally invasive approach. As
an alternative to more aggressive treatment options,
image-guided focal laser ablation has the potential to
change the paradigm for prostate cancer therapy for
patients with low- and intermediate-risk disease.
The research described was supported by the Partnership for Cures
Foundation and Visualase Inc.
10

Tanguy Seiwert, MD
Assistant Professor of Medicine
CLASSIFYING
PATIENTS WITH HEAD
AND NECK CANCERS
Tanguy Seiwert, MD, assistant
professor of medicine,
discovered that head and
neck cancers can be classified
into five subtypes,
each with unique characteristics
that may guide
the selection of therapies
for individual patients.
Using advanced genomic and bioinformatic analyses to
profile 134 head and neck tumors, Dr. Seiwert and his
team observed that characteristics associated with treatment
success were not evenly distributed. For example,
human papilloma virus (HPV)-associated head and neck
cancer, a group of tumors with a generally favorable
prognosis, can be divided into two groups — one with a
very favorable response and one with a poorer prognosis.
This work, combined with ongoing studies that are
examining the mutational fingerprints of each subtype,
is advancing personalized medicine approaches for
patients with head and neck cancer.
This work was supported by an ASCO Translational Professorship Award
(Dr. Everett Vokes), the Flight Attendant Medical Research Institute, and a
grant supported by Grant Achatz.
Ernst Lengyel, MD, PhD
Professor of Obstetrics and
Gynecology
A NEW MODEL OF
OVARIAN CANCER
Ovarian cancer is dubbed
the “silent killer” because
the disease often goes
undetected until it has
spread extensively. Ernst
Lengyel, MD, PhD, professor
of obstetrics and
gynecology, discovered
that tumors migrate to
the omentum, tissue that
stores fat and protects
abdominal organs, because they are attracted to fat cells
(Nieman et al., Nat Med 17:1498-503, 2011). He designed a
novel 3D model to further study how ovarian cancer cells
spread in the abdomen. To construct the model, primary
cells were extracted from normal human omentum and
combined with cancer cells in a manner that mimics
the human body much better than cultured cell lines on
plastic, the standard model used to study cell interactions.
Dr. Lengyel’s team is now adapting the 3D culture
for high-throughput screening with thousands of drug
candidates to identify novel drugs for the treatment
of patients with advanced ovarian cancer. By halting
metastasis, this work may change the paradigm for ovarian
cancer treatment, which currently involves debulking
surgery and chemotherapy.
This work was supported by the National Cancer Institute of the National
Institutes of Health, the Burroughs Wellcome Fund, and the Cancer
Research Foundation (Fletcher Award).
Suzanne Conzen, MD
Professor of Medicine
OVERCOMING
CHEMOTHERAPY
RESISTANCE
Suzanne Conzen, MD,
professor of medicine,
has discovered a new
approach to breast cancer
therapy that may soon
benefit patients with
chemotherapy-resistant
tumors. Using a mouse
model of human breast
cancer, Dr. Conzen combined chemotherapy with a
drug that neutralizes the activity of the glucocorticoid
receptor, a protein that is involved in stress signaling.
Dr. Conzen found that the treatment combination was
nearly 50% more effective than chemotherapy alone.
Working with Rita Nanda, MD, assistant professor of
medicine, this approach is being tested in a Phase I
clinical trial evaluating whether inhibition of the glucocorticoid
receptor enhances chemotherapy response
for estrogen-insensitive breast cancers and for
those tumors that are initially classified as “triplenegative”,
or lacking HER2, estrogen, and progesterone
receptor expression.
This work is being supported by the National Institutes of Health, the Avon
Foundation, and the Susan G. Komen for the Cure Foundation.
Wendy Stock, MD
Professor of Medicine
YOUNG ADULTS
FARE BETTER
ON PEDIATRIC
CANCER TREATMENT
REGIMENS
Wendy Stock, MD, professor
of medicine, and her
colleagues in the Cancer
and Leukemia Group B
(CALGB) and the Children’s
Oncology Group
(COG) found that adolescents
and young adults with newly diagnosed acute
lymphoblastic leukemia (ALL) had significantly improved
survival rates when treated on pediatric protocols
in comparison to adult regimens (Stock et al., Blood
112:1646 – 54, 2008). This study was the first to identify
a surprisingly large disparity in survival for young adults
with ALL depending on how and where they were
treated, and has led to international efforts to evaluate
pediatric-inspired regimens. As a result, the UCCCC created
the Adolescent and Young Adult (AYA) Oncology
Program, the first of its kind in the Midwest, to provide
specialized care and psychosocial support for this group
of patients. Staffed by doctors and nurse practitioners
from both pediatric and adult programs, the center
offers personalized care to AYA patients with hematological
malignancies.
The research described was supported by the National Institutes of Health.
from bench to bedside
11

expanding our reach
The UCCCC continues to accelerate the growth of our clinical cancer programs
through biomedical advances in areas including genomics, imaging, and
computation. Driving forward these advances to bring new hope to patients,
the University of Chicago Medicine has constructed two new medical facilities
that expand comprehensive care to our communities.
Center for Care and Discovery
Nearing completion after three years of construction,
the Center for Care and Discovery represents the largest
single healthcare investment in the University’s history.
At 1.2 million square feet and soaring 10 stories high over
two city blocks, the Center for Care and Discovery is a
“hospital for the future” devoted to complex specialty
care, with a focus on cancer, gastrointestinal disease,
medical imaging, neuroscience, and advanced surgical
programs. Expected to be one of the most sophisticated
hospitals in the world, its design can be easily transformed
to meet the rapidly changing needs of patient
care and clinical research for decades to come.
Opening in February 2013, the new hospital will equip
our physicians and scientists with the most advanced
diagnostic tools and surgical technologies to provide
exceptional, customized care. For example, patients with
lung cancer will benefit from navigation bronchoscopy, a
procedure used to sample nodules and masses, which is
safer than needle biopsies and reaches deeper into the
lung than normal bronchoscopy. The Center for Care and
Discovery is the first and one of only a handful of centers
in Illinois to offer this technology. Tools such as this and
endobronchial ultrasound, which permits lymph node
sampling in the middle of the chest without surgery,
allow our physicians to formulate personalized treatments
more efficiently based on the genetic profile of
the patient’s tumor.
With an entire floor exclusively devoted to cancer, the
Center for Care and Discovery will expand the UCCCC’s
capacity to treat patients from local communities and
from around the world with individualized treatments
not found in most hospitals. The Center for Care and
Discovery serves as an optimal setting for collaborative
clinical research and patient care, and is advantageously
located across the street from the Gordon Center for
Integrative Science and the Knapp Center for Biomedical
Discovery, which house our state-of-the-art research
laboratories. This proximity bridges our world-class
physicians and scientists as they work together to shape
the future of cancer care.
Comprehensive Cancer Center at
Silver Cross Hospital
The UCCCC marked another significant milestone this
summer by opening the University of Chicago Medicine
Comprehensive Cancer Center at Silver Cross Hospital
in New Lenox, Ill. The brand-new outpatient facility
enables adult and pediatric patients living in Will County
to receive comprehensive cancer care in a setting
close to home. The $21.6 million, 20,000-square-foot
facility houses many of the advanced treatment techniques
found at our urban medical center, including a
linear accelerator that uses image-guided and intensitymodulated
radiation therapy to deliver safe and
precise treatments.
Our patients experience multidisciplinary care, where our
radiation, medical, and surgical oncologists collaborate
to determine the most effective, individualized treatment
options. Patients in both the urban and community
settings have access to the UCCCC’s innovative clinical
trials, which offer improved treatments based on our
research advances. Equipped with the newest therapies
and technologies, we are committed to excellence in
patient care.
Above: Silver Cross Infusion Room
Opposite page: Center for Care and Discovery
expanding our reach
13

planting the seeds
of survivorship
Survivorship starts from the time of
diagnosis, yet many cancer patients
find themselves wholly unprepared
for what lies ahead. The UCCCC offers
several personalized survivorship clinics
and services to our patients and their
families as they face the challenges of
a cancer diagnosis and beyond.
Childhood Cancer Survivors Center
Cancer survivorship is especially important for children diagnosed with cancer.
These patients face a lifetime risk for a host of medical problems resulting from
cancer therapy, including secondary cancers, endocrine disorders, and heart and
renal problems, as well as issues with growth, development, and fertility. Led by
Tara Henderson, MD, MPH, assistant professor of pediatrics, our Childhood Cancer
Survivors Center screened 200 patients this year for long-term health problems and
second malignancies. The Center, which recently expanded in conjunction with the
new Adolescent and Young (AYA) Adult Oncology Program to include all cancer
survivors diagnosed with cancer before the age of 30, educates survivors on their
health risks and develops individualized recommendations for long-term health
maintenance. Our experts address survivorship issues through research, including
national studies with the Children’s Oncology Group, a National Cancer Institutesupported
program that aims to improve pediatric therapies. Dr. Henderson and
other UCCCC physicians also participate in the Childhood Cancer Survivorship Study,
the largest national cohort of 14,000 childhood cancer survivors, and are actively
investigating the risk factors and impact of surveillance on the development of
secondary cancers.

Breast Cancer Survivorship Program
Breast cancer survivors make up the largest proportion
of the 12 million survivors alive today. Our Breast Cancer
Survivorship Program offers patients a personalized
approach to survivorship from the time of diagnosis
through treatment. A multidisciplinary team of specialists,
including medical and radiation oncologists,
radiologists, surgeons, and psycho-oncologists counsels
patients and their families on topics including the
long-term side effects of treatment, family history of the
disease, fertility issues, nutrition and healthy lifestyles,
and warning signs of disease recurrence. “We deliver
outstanding care through a team-based approach that
considers each patient’s unique set of circumstances,”
said Susan Hong, MD, MPH, director of the Program. This
past year, the Program supported nearly 250 patients,
who are now educated about their disease and better
prepared to take action.
Project ECHO
The UCCCC has stepped up our efforts in survivorship
this year by implementing Project ECHO (Extension for
Community Healthcare Outcomes), a unique program
that partners our physicians with primary care providers
at Chicago community health centers to develop
new approaches for providing underserved patients
with specialized care. Our institution is the first to apply
Project ECHO in an urban setting, and also the first to
apply the program toward cancer care. The UCCCC
implemented the breast cancer survivorship portion of
the program, which spans over 6 months and uses teleconference
technology, disease management tools,
and expertise found only at an academic medical center
to deliver didactic lectures to community physicians.
The program addresses a wide range of topics, including
national guidelines for follow-up care, long-term
management of the side effects from cancer treatment,
and identification of patients at risk for hereditary
cancer syndromes. Funded by the American Cancer
Society — Illinois Division, this program extends the
reach of our comprehensive care.
Cancer Transitions
Among other survivorship resources, the UCCCC offers
our patients the “Cancer Transitions: Moving Beyond
Treatment” program developed by the LIVESTRONG®
organization to support, educate, and empower individuals
during the transitional period following cancer treatment.
The program enables cancer survivors and their
families to develop skills and tools to address exercise,
nutrition, emotional health, quality of life, and medical
management. This year, the UCCCC Office of Community
Engagement and Cancer Disparities (OCECD)
tailored the program to meet the cultural and linguistic
needs of cancer survivors in our local Chinese community
by conducting sessions in Mandarin, Cantonese, and
English, and featuring lessons in Tai Chi. The program is
now offered on a bimonthly basis because of its positive
impact within the Chinese community.
PRISM Clinic
The UCCCC’s Program in Integrative Sexual Medicine
(PRISM) for Women and Girls with Cancer is the first
clinic in Illinois — and one of only a few nationwide —
devoted to helping female cancer patients and survivors
manage sexual health problems related to their disease
or treatment. During and after cancer treatment, women
often experience symptoms such as vaginal dryness,
painful intercourse, and a lack of interest or pleasure.
Staffed by specialists who provide education and support
during all stages of treatment and recovery, the
clinic uses a team approach that includes discussion with
the patient, the patient’s oncologist, and a psychologist.
Some patients may benefit from over-the-counter products,
while others may need physical therapy or psychotherapy.
The clinic is a national model for bringing the
sexual problems of women with breast or gynecological
cancers to the forefront of survivorship discussions.
Above: Cancer patient, Natachie, with family
Opposite page: Dr. Navin Pinto performing an exam with patient
planting the seeds of survivorship
15

My name is Vincent.
I am a nurse in the emergency
department.
I use humor to make people
smile every day.
My dog Petie is my best friend
and keeps me going.
vincent’s story
17

I’m a survivor.
An unexpected hospital stay left quite an impression
on Vincent Davenport when he was 18. He remembered
being very gently cared for by people walking around in
white. This experience inspired him to pursue a career in
healthcare. The 58-year-old Chicagoan currently works at
the Bernard A. Mitchell Hospital at the University of Chicago
Medicine, where he enjoys caring for patients amid
the fast-paced action of the emergency department.
Yet, Vincent is once again finding himself on the receiving
end of care — this time, as a cancer patient. Three
years ago, he noticed occasional abdominal discomfort
and fatigue. Several coworkers were concerned about
his increasingly thin and pale appearance. By the time he
saw his doctor, vomiting had become another symptom.
A CT scan showed a tumor in his abdomen. “I guess I
wasn’t surprised because I knew something was different
with my body,” he said. The next day, Vincent underwent
surgery to remove the tumor from his colon, which was
discovered to be cancerous. Aware of the outstanding
reputation in cancer care, he decided to continue treatment
at the UCCCC, where he received chemotherapy.
One year later, the cancer appeared in his liver and lungs.
This time, Vincent’s care relied on the innovative therapies
offered through the UCCCC’s clinical trials program,
which often tailors treatment based on genetic information.
Vincent was placed on a clinical trial that adjusted
the dosage of his chemotherapy based on his genetic
profile. The trial allowed him to receive a 50% higher
dose of treatment than what he would have received
under standard treatment. As a result, Vincent’s lesions
have shrunk.
“I realize that I have a life-threatening illness; my head is
not in the sand,” Vincent said. “But I feel comfortable in
my doctor’s hands and am taking everything as it comes.”
Vincent may have inherited that resilience from his
83-year-old mother, who survived lung cancer against all
odds. He has also talked with his 35-year-old son about
surveillance, since having a family member with a history
of colon cancer and being African American are two
known risk factors for colon cancer.

“I’m doing
wonderful,
and I’m thankful
for every day
that I’m here. The
experience has
helped focus ”
Vincent attributed his positive outcome to the high level
of care he receives — and not because he is a hospital
employee. He noticed all patients are treated with expert
care from doctors and nurses who work well together.
In addition to family and coworkers who watch him “like
a hawk,” Vincent is grateful for his Yorkshire terrier, Petie,
gives him something to focus on besides his cancer. “I
can feel myself relaxing when he’s around,” he said.
— VINCENT DAVENPORT
Looking Forward...
In addition to adjusting chemotherapy dosage based
on a patient’s genetics, UCCCC researchers are examining
whether adjusting the timing of chemotherapy
can provide added benefit for patients. In an ongoing
trial for rectal cancer, our researchers are testing
whether chemotherapy offered earlier in the treatment
process is more effective and can prevent the need for
surgery. Many patients who undergo surgery require
permanent colostomy bags, so avoiding surgery
altogether would minimize complications and greatly
improve quality of life.
vincent’s story
19

Reducing Cancer in
our Community
We help those around us learn about
cancer and take charge of their health.
To ensure quality cancer care for our patients, the UCCCC Office of Community Engagement
and Cancer Disparities (OCECD) identifies emerging cancer issues and engages
in outreach activities in our surrounding communities, which are predominantly African
American, as well as within the Asian, Hispanic, and Native American communities.
Led by Karen E. Kim, MD, MS, professor of medicine, the OCECD builds strategic
partnerships with community, ethnic, and faith-based organizations to develop culturally
adapted awareness and screening programs, as well as educational resources
to engage patients in research and clinical trials. Each year, OCECD staff meets with
hundreds of individuals through numerous community events, ranging from health fairs
to cancer support groups to workplace wellness programs.

Raising Awareness
Empowering Neighborhood Resources in Combating
Health Disparities (ENRICH’D) is our signature educational
program sponsored in part by a grant from Exelon
Corporation. Launched in 2011, the OCECD worked with
Chicago public high schools to design culturally and
language-adapted resource guides to raise breast and
prostate cancer awareness in the African American and
Asian communities. Already reaching over 700 community
members, the program is closing gaps in healthcare
knowledge and encouraging healthier lifestyles.
Complementing these efforts, the OCECD launched a
new “Walk Through” program to familiarize community
members with medical resources at the UCCCC. Showcasing
our breast cancer program, participants obtain
a firsthand view of cancer screening and treatment
options, and learn of the strengths of our UCCCC Breast
Cancer Survivorship Program.
Also noteworthy is our success in promoting colorectal
cancer prevention. Supported by the Illinois Cancer Partnership,
the OCECD organized a statewide initiative this
year that provided more than 2,000 colorectal cancer
screenings to individuals 50 and older in 45 community
organizations and hospitals.
Enhancing Education
With a newly awarded National Cancer Institute planning
grant, the UCCCC is working closely with Chicago State
University (CSU), the largest minority serving institution
in the Midwest, to enhance graduate student education.
Over the next two years, the UCCCC will develop
a new cancer curriculum that focuses on outreach and
health disparities for incorporation into the CSU’s Master
of Public Health program. By disseminating our cancer
disparities research and education, we are advancing the
training of a diverse public health workforce, as well as
learning about our community’s needs and attitudes.
Through these and other programs, we have formed
strong community partnerships to help us engage in
health disparities research. Our goal is to understand
the biological, racial, ethnic, economic, and geographic
issues that contribute to cancer health disparities in
our surrounding communities through clinical trials and
community-based participatory programs. By understanding
these barriers, we strive to promote new ways
to prevent cancer.
Above (from top): Participants of a colorectal cancer screening
initiative in the Korean community sponsored by the OCECD in
partnership with the Asian Health Coalition and Hanul Family
Alliance; Cancer patient, Natachie, with family
Opposite page: Chicago public high school students participating
in the OCECD’s ENRICH’D program
reducing cancer in our community
21

shaping the future
of cancer care
Since its founding in 1973 as one of
the first National Cancer Institutedesignated
Cancer Centers, the UCCCC
has developed innovative research
and multidisciplinary clinical treatment
programs to elevate cancer care. Our
challenge over the next decade is to
accelerate the translation of research
discoveries into personalized care
that is efficiently incorporated into
medical practice. In pursuit of this
challenge, we have launched a bold
five-year strategic plan addressing
the continuum of cancer care.

Cancer Prevention
and Population Research
Available data indicates that ~65% of cancers in the U.S.
could be prevented. The UCCCC is creating a trans-
University Center for Cancer Prevention and Population
Research to investigate the causes and risk factors of
cancer, as well as the roots of cancer disparities. Our
researchers are establishing a unique multi-ethnic cohort
of 100,000 individuals who are healthy, at high-risk for
cancer, or have been diagnosed with cancer to carry
out these investigations from a population perspective.
By identifying patients at high risk and developing new
interventions and diagnostics for these individuals, the
Center aims to make groundbreaking discoveries that
translate to sustainable disease prevention programs.
Science-Based Personalized Medicine
The UCCCC is implementing cancer care based on
the patient’s genome, environmental exposures, and
personal behaviors to achieve the best health outcomes.
However, cancer has the capacity to evolve and escape
even the best targeted therapies. To tackle this formidable
challenge, the UCCCC is undertaking three major
initiatives to elucidate the molecular and physiological
heterogeneity of cancer. In the Basic Science Initiative,
UCCCC research teams are evaluating tumor specimens
using state-of-the-art technologies to address key
challenges in cancer progression and treatment. For
example, computational scientists and cancer biologists
are working together to develop genetic signatures to
identify patients who are more likely to remain metastasis-free
following therapy. In the Translational Sciences
Initiative, UCCCC researchers are advancing the development
of new non-invasive imaging tools for clinical
diagnostics and assessment of treatment response, as
well as the discovery of new cancer therapeutics, which
is driven by the bi-directional flow of science between
the laboratory and the clinic.
To advance patient care through its Clinical Science
Initiative, the UCCCC has created the Personalized
Cancer Care Consortium comprising the University of
Chicago and affiliated regional hospitals. The Consortium
is enrolling patients in clinical studies to test new
cancer interventions. Serving as a clinical and research
hub for these studies, the Consortium will enable UCCCC
researchers to develop cancer biomarkers to predict
therapy response, new imaging strategies to evaluate
cancer, and personalized therapeutic approaches to
deliver the right treatment at the right time.
Improving Survivorship and Outcomes
While advances in cancer treatment promise longer life
with fewer side effects, they present profound economic,
political, and psychosocial issues. For example, how will
the cost of cancer care be affected by new, expensive
therapies that are effective in only a small niche of
patients How will major disparities in cancer care be
addressed in underserved populations How will society
meet the medical and social needs of a growing
pop ulation of cancer survivors To address these
questions, the UCCCC is creating a new Cancer Outcomes
and Survivorship Program to develop new
models of healthcare delivery and reimbursement,
as well as social policy to enhance the efficiency and
equity of healthcare. Research will span across the
cancer spectrum and focus on cancer survivorship,
the psychosocial manifestations of cancer, cancer
economics, and outcomes research.
Through these initiatives, the UCCCC is endeavoring
what no other institution has yet managed. By integrating
our institution’s rich academic environment in biological,
physical, and social sciences with expertise
in medicine, economics, and public policy, the UCCCC
is truly tackling cancer from all angles and developing
new standards for cancer care.
Opposite page: UCCCC Director Michelle M. Le Beau, PhD and
Dr. Habibul Ahsan
shaping the future of cancer care
23

A SNAPSHOT
OF CANCER
CARE
24

Advancing Oncology Services
Ranked #15 in the nation by U.S. News & World
Report, the highest ranking institution in Illinois,
our cancer program remains steadfast in our goal
to provide the highest quality cancer care services
to our patients and community.
The UCCCC Cancer Registry provides a full range of
oncology data services for our nationally recognized
American College of Surgeons (ACoS)-approved clinical
cancer program. Since the 1920s, the Registry has collected,
maintained, and reported detailed information
for patients diagnosed with, and treated for, cancer or
benign central nervous system neoplasms. A dedicated
team of data management specialists ensures that
records are maintained for patients at both the University
of Chicago Medicine and the newly opened University
of Chicago Medicine Comprehensive Cancer Center at
Silver Cross Hospital.
The Cancer Registry provides important data services
to advance basic, translational, and clinical research at
the UCCCC. All data collected by the Registry can be
accessed via an electronic data repository, known as the
Clinical Research Data Warehouse (CRDW). Researchers
and clinical staff who request access to this resource are
provided data in a safe, managed method that is compliant
with HIPAA Privacy and Security Rules. Registry data
are essential for not only advancing research to improve
patient care, but also for cancer program development,
community outreach activities, and decision-making in
oncology and public healthcare policies.
a snapshot of cancer care
25

2011 Cancer Data 1
Cancer Incidence by Type
In 2011, 3,660 patients were diagnosed and/or treated at the
University of Chicago Medicine for a malignancy or benign
central nervous system neoplasm (See Table 1).
Of these, the majority of patients (3,030, 83%) were newly
diagnosed, and the remaining (630, 17%) had recurrent or
progressive disease. The most frequently seen cancers were
of the digestive system (556, including colorectal cancer), male
genital system (446, including prostate cancer), breast (337),
respiratory system (315, including lung cancer), and urinary
system (216, including kidney cancer).
Figure 1. 2011 Cancer Cases by Gender and Age at Diagnosis
Table 1. 2011 Cancer Cases by Site
Primary Site
Newly
Diagnosed
Recurrent/
Progressive
Disease
Total
% of
Total
Progressive Disease 531 111 642 17.5%
Digestive System 478 78 556 15.2%
Male Genital System 372 74 446 12.2%
Breast 311 66 377 10.3%
Respiratory System 262 53 315 8.6%
Urinary System 182 34 216 5.9%
Endocrine System* 167 34 201 5.5%
AGES 0 – 29
107 93
AGES 30 – 39
116 75
Oral Cavity and Pharynx 137 39 176 4.8%
Female Genital System 128 38 166 4.5%
Lymphoma 124 33 157 4.3%
AGES 40 – 49
Leukemia 62 18 80 2.2%
268 182
Skin (Excluding Basal and Squamous) 105 17 122 3.3%
AGES 50 – 59
393 511
AGES 60 – 69
389 629
AGES 70 – 79
Brain and Other Nervous System** 46 10 56 1.5%
Miscellaneous*** 42 7 49 1.3%
Soft Tissue 33 11 44 1.2%
Myeloma 24 3 27 0.7%
292 334
Bones and Joints 22 2 24 0.7%
AGES 80 – 89
Mesothelioma 3 2 5 0.1%
136 115
Eye and Orbit 1 0 1 0.1%
FEMALE
MALE
AGES 90+
12 8
Kaposi Sarcoma 1 0 1 0.1%
Total 3,030 630 3,660 100%
1
The Cancer Registry reports on patients who were newly diagnosed and/or received their first
course of treatment for cancer progression or recurrent disease at the University of Chicago
Medicine. The total number of patients seen with cancer, including all consult visits, is higher.
* includes benign pituitary adenomas
** includes benign neoplasms
*** includes blood dyscrasias, myelodysplastic/myeloproliferative disorders
and cancers with other histology/primary site designations
26

Figure 2. 2011 Cancer Cases by Gender and Race/Ethnicity
1,324
WHITE MALES
77
HISPANIC MALES
76
HISPANIC FEMALES
45
ASIAN PACIFIC ISLANDER MALES
57
ASIAN PACIFIC ISLANDER FEMALES
1,023
WHITE FEMALES
82
UNKNOWN MALES
41
UNKNOWN
FEMALES
419
AFRICAN AMERICAN MALES
516
AFRICAN AMERICAN FEMALES
Figure 3. 2011 Patient Residence at Diagnosis
81%
ILLINOIS RESIDENTS
BY COUNTY
2,966 PATIENTS ARE
FROM ILLINOIS
62.7%
COOK COUNTY (1,800)
10.9%
WILL COUNTY (323)
9.1%
DUPAGE COUNTY (271)
5.1%
LAKE COUNTY (152)
19%
NON-ILLINOIS RESIDENTS
680 PATIENTS ARE FROM
OTHER STATES/COUNTRIES
78%
INDIANA (531)
8.5%
MICHIGAN (58)
3.8%
WISCONSIN (26)
2%
OUTSIDE OF THE U.S. (14)
ISRAEL, MEXICO, UNITED
ARAB EMIRATES, CHINA,
BRAZIL, CANADA, PANAMA,
POLAND, ROMANIA, AND
SAUDI ARABIA
Patient Demographics
More than half of all patients (1,922, 52.5%) were diagnosed between the ages of
50 and 69 years (See Figure 1). Distribution by gender reveals a higher number of
male patients (1,947, 53.1%) than females (1,713, 46.8%). Distribution by race (See Figure
2) shows that our patient population is predominately white (2,347 patients, 64.1%),
followed by African American (935 patients, 25.5%), and Hispanic (153 patients, 4.2%).
These trends are similar to those seen in recent years.
Patient Geographics
The majority of patients (2,966, 81.0%) seen in 2011 were Illinois residents (See Figure 3),
with the highest number residing in Cook County (1,860, 62.7%) followed by Will County
(323, 10.9%), DuPage County (271, 9.1%), and Lake County (152, 5.1%).
Nearly 19% (680 patients) of the total number of patients first seen in 2011 lived outside
of Illinois, primarily in the neighboring states of Indiana (531, 78.0%), Michigan (58, 8.5%)
and Wisconsin (26, 3.8%).
We also served 14 international patients from countries including Israel and Saudi Arabia
(three patients each), England, China, Palestine, Kuwait, Venezuela, Japan, Romania, and
United Arab Emirates (one patient per country).
a snapshot of cancer care
27

I’m Steve.
I love computers, video games, and
singing karaoke with my friends.
I had leukemia, but now I’m in remission
and my life is almost normal again.
Steve’s story
29

I’m a survivor.
Two years ago, Steve Kegebein couldn’t understand why
he was so sick for an entire month with flu-like symptoms.
A doctor in Indiana diagnosed Steve, at age 24, with
acute myeloid leukemia (AML). His white blood cell
counts were so high that he was immediately rushed
to the UCCCC, which is renowned for its adult leukemia
program and many important contributions to the
classification of leukemias, as well as the understanding
of genetics and cancer. He remembers the shocked
reactions of his family and friends. “They knew I was
sick, but nobody expected anything like that,” he said.
“I saw a lot of people in tears that I’d never seen cry
before in my life — it was strange.”
Steve was first treated in the intensive care unit with
a pheresis procedure and chemotherapy to reduce the
high number of leukemic cells in his blood. Once he
was stabilized, he began aggressive chemotherapy on
a clinical trial which controlled the disease, followed by a
bone marrow transplant from one out of 400 unrelated
donor matches. However, three months later, the leukemia
relapsed. Andrew Artz, MD, assistant professor of
medicine, then enrolled Steve on a clinical trial for a drug
that specifically targets the FLT3-ITD mutation found in
Steve’s type of AML. Disease control was accomplished
and Steve then underwent a second transplant in conjunction
with high-dose chemotherapy adjusted to
achieve the exact desired drug exposure; after the transplant,
Steve was placed on a different targeted drug.
He has remained in remission since then and comes back
for three-month check-ups.
The UCCCC has an unmatched record in leukemia
research and was among the first centers in the country
to test experimental leukemia drugs in clinical trials.
UCCCC scientists and clinicians continue to test the
newest generation of targeted therapies and develop
individualized treatment plans for patients with leukemia.
“It never crossed my mind that something could
potentially go bad and that I wouldn’t make it through it,”
Steve said, adding his outlook was more like, “What do
we have to do to get through it”

“I love the UCCCC
because they
really took
care of
I wouldn’t have
wanted to be
anywhere else.”
— STEVE KEGEBEIN
During Steve’s lengthy hospital stays, many of his loved
ones kept him company. He preferred being in the hospital
to home because he felt comfortable knowing his
nurses and doctors were right there to help him. To pass
time, he played video games. “I logged a lot of hours
from that hospital bed,” he said. “It helped that I had
something to do that I enjoyed.”
Other than reassuring his loved ones he was going to
be okay, Steve said the most difficult parts of the
experience were the painful bone marrow biopsies and
being too sick to eat. Now, Steve is enjoying a lot of
the things that remind him of his life before leukemia,
including steak and lobster from Japanese hibachi
grills. He resumed his job driving and unloading trucks
with UPS, which he loves, and plans to return to school
for sociology. He regularly sings karaoke with his
friends and recently placed third in a contest.
Looking Forward...
FLT3 is the second most common gene mutation in
adult patients with AML. The UCCCC is conducting
clinical trials to test novel agents that specifically target
FLT3, including midostaurin, lestaurtinib, sorafenib, and
quizartinib. These agents have not yet been approved
by the FDA for the treatment of AML. Researchers
hope that using one of these targeted therapies, when
combined with conventional chemotherapy, will one day
reduce the need for allogeneic transplants altogether.
Steve’s story
31

focus on colorectal cancer
Colorectal cancer is recognized as the third most
common cancer and the second leading cause of
cancer deaths worldwide.
The UCCCC is committed to preventing and reducing
the burden of this disease and other cancers. Patients
benefit from our high level of comprehensive care for
colorectal cancer — our experts are pioneering preventive
strategies, improving quality of life, developing new
therapies, and educating our community through
culturally adapted outreach efforts.
The American Cancer Society estimates that in 2012,
more than 73,000 new cases of colorectal cancer will
be diagnosed and roughly 52,000 Americans will die
from the disease. Over the past five years, the number
of patients diagnosed with and/or treated for colorectal
cancer at the University of Chicago Medicine has
remained relatively stable. On average, we see over 150
newly diagnosed and/or treated patients with colorectal
cancer at the University of Chicago Medicine each year. 1
A Team-Based Approach
The UCCCC’s power of collaboration brings together
multiple medical disciplines to provide the best care for
our patients. For colorectal cancer, a dedicated team
of surgical oncologists, medical oncologists, radiation
oncologists, radiologists, geneticists, and interventional
gastroenterologists uses the most detailed diagnostic
imaging scans alongside clinical and biological data to
formulate individualized treatment plans, which often
revolve around the patient’s quality of life.
According to Blase Polite, MD, MPH, assistant professor
of medicine, “When we treat patients, part of our holistic
approach is to carefully consider each patient’s life
and to address their fears and concerns.” For example,
colorectal surgeons are pioneering minimally invasive
robotic surgeries for patients with rectal cancer to speed
recovery and reduce the number of patients who need
permanent colostomy bags.
Translating Research into
Improved Care
Pushing beyond the standards of care, the UCCCC offers
unique treatments for our patients. Our researchers
are testing new therapeutic strategies and placing the
highest priority on personalized care through innovative
clinical trials. For example, researchers have been able
to increase the standard dose of chemotherapy by more
than 50% in certain patients, using genetic profiles as
a guide, without increasing the toxicity of treatment.
In an ongoing trial in rectal cancer, our physicians are
determining whether offering chemotherapy earlier
in the treatment process is more effective, better tolerated,
and reduces the complications of surgery. One day
we may be able to avoid surgery altogether in some
of these patients.
While improving the effectiveness of existing therapies,
we are simultaneously developing the next generation of
drugs to treat chemotherapy-resistant tumors. Several
ongoing clinical trials are testing the effectiveness of
new targeted therapies. In one study, our researchers
are using a novel monoclonal antibody to deactivate
MET, a protein that is associated with poor outcomes in
many cancers, in combination with chemotherapeutic
From top: Drs. Blase Polite and Sonia Kupfer;
Dr. Stanley Liauw and patient
1
The Cancer Registry reports on patients who were newly diagnosed and/or received their first course of treatment for cancer progression
or recurrent disease at the University of Chicago Medicine. The total number of patients seen with colorectal cancer, including all consult
visits, is higher.
32

Figure 4. 2011 Colorectal Cases by Gender and Age at Diagnosis
AGES 0 – 29
1 1
AGES 30 – 39
11 10
AGES 40 – 49
11 10
AGES 50 – 59
18 34
AGES 60 – 69
22 31
AGES 70 – 79
15 24
AGES 80 – 89
15 7
drugs as a front-line treatment for colorectal cancer. We are also evaluating the safety
and effectiveness of combining standard chemotherapy with a monoclonal antibody
targeted against the KRAS protein for patients with KRAS mutations. These mutations
are associated with worse survival rates in colorectal cancer patients.
To complement these efforts, the UCCCC runs a cancer risk group to support young
patients with colorectal cancer and those with extensive family histories of the disease.
Our physicians are also developing a colorectal cancer survivors’ clinic to help patients
maximize their health after cancer treatment.
A Snapshot of Colorectal Cancer 1
In 2011, the University of Chicago Medicine newly diagnosed and/or treated 212 patients
with colorectal cancer. Half of all patients seen were between the ages of 50 and 69,
and in this age group, more than half (65, 61.9%) were male (See Figure 4). Analysis of
the distribution by race (See Figure 5) shows that our patient population for colorectal
cancer is predominately white (133, 62.7%), followed by African American (64, 30.1%),
Hispanic (8, 3.7%), and Asian and Pacific Islander (7, 3.3%). The number of African
American patients seen with colorectal cancer is significantly higher (30%) compared
AGES 90+
1 1
FEMALE
MALE
Figure 5. 2011 Colorectal Cases by Race and Ethnicity
5
HISPANIC MALES
3
HISPANIC FEMALES
4
ASIAN PACIFIC
ISLANDER MALES
3
ASIAN PACIFIC
ISLANDER FEMALES
31
AFRICAN AMERICAN
MALES
33
AFRICAN AMERICAN
FEMALES
Figure 6. 2011 Survival Rates for Patients with Stage IV Colon Cancer
52.9
32.1
62
38
26
19.5
UNIVERSITY OF
CHICAGO MEDICINE
NATIONAL CANCER
DATA BASE
14.6
78
WHITE MALES
55
WHITE FEMALES
20.7
1 2 3 4 5
YEARS AFTER DIAGNOSIS
11.4
14.6
focus on colorectal cancer
33

with the national average of 10%, reflecting the predominance
of this population in our surrounding community
and our commitment to their care.
Figure 6 shows one- to five-year survival rates for
patients diagnosed with stage IV colon cancer. At the
University of Chicago Medicine, patient survival rates
range from 62% one year following diagnosis to nearly
15% five years following diagnosis. Despite treating
some of the most complex cases, we are proud that
our patient survival rates compare favorably with the
national survival rates.
Exploring the Mechanisms of
Colorectal Cancer
To understand the factors that contribute to colorectal
cancer, UCCCC scientists are exploring environmental
and biological factors through basic research studies.
For example, Marc Bissonnette, MD, associate professor
of medicine, is examining the mechanism by which highfat
diets promote colorectal cancer and how vitamin
D acts as a chemopreventive agent. Sonia Kupfer, MD,
assistant professor of medicine, is pinpointing genetic
variations that may increase the risk of colorectal cancer
across different ethnic populations. As another example,
Kathleen Goss, PhD, assistant professor of surgery, is
studying the mechanism by which the APC tumor suppressor
inhibits the development of colorectal cancer.
These and other studies underway at the UCCCC provide
the foundation to develop improved therapeutics
and test new strategies to prevent cancer in clinical trials.
Preventing Colorectal Cancer
UCCCC researchers place a heavy emphasis on tackling
colorectal cancer disparities in local neighborhoods and
around the world. “Not only are we looking at colorectal
cancer at the genetic and biological level, we are also
studying the social and environmental factors which may
cause disparities,” said Dr. Polite. “We want to make sure
our successes in clinical research are being shared by all
members of our community.”
Only approximately 60% of Illinoisans 50 and older are
screened for colorectal cancer. Among minority populations,
screening rates are even lower. In response, the
UCCCC launched a statewide initiative in partnership
with the American Cancer Society-Illinois Division to
provide an equal opportunity for individuals to benefit
from colorectal cancer screening. “Many people who
can benefit from colorectal cancer screening fail to get
screened; this is particularly the case among minority
populations who may be challenged by numerous barriers,
including access, language, and fear,” said Karen E.
Kim, MD, MS, professor of medicine and director of the
UCCCC Office of Community Engagement and Cancer
Disparities (OCECD).
The OCECD has undertaken several initiatives to disseminate
colorectal cancer education and expand colonoscopy
access to Chicago’s uninsured Southside residents,
which include African American and Asian American
communities. African Americans have the highest incidence
of colorectal cancer and the highest mortality rate
for the disease in the U.S. “If we can improve screening
rates, we should be able to reduce the number of deaths
from colorectal cancer for all populations in the state
of Illinois,” said Dr. Kim. The OCECD has also formed a
research task force in partnership with the Asian Health
Coalition to study how race/ethnicity and language
proficiencies of instructors in community education programs
impact colorectal cancer screening in the Korean
immigrant population.
Hands-On Education
To provide a firsthand view of how our distinguished
cancer research programs translate to the clinic, the
UCCCC launched Project Cancer Education, a program
originally developed by the Ohio State University with
the Association of American Cancer Institutes. This year,
board members of the University of Chicago Cancer
Research Foundation attended the program to learn
about the necessity and role of research in the clinical
care of patients with colorectal cancer.
Participants went on a behind-the-scenes tour of UCCCC
research facilities and learned about innovative clinical
trials and experiments in progress. They also learned
about the submittal process for peer-reviewed scientific
journals, as well as research funding sources. “Project
Cancer Education allowed participants to step into my
shoes for an hour and understand the excitement and
challenges of life as a physician-scientist,” said Dr. Kupfer.
This successful event was the first UCCCC initiative
focused on educating community members on the
importance of cancer research funding and the role of
research discoveries in advancing patient care.
34

Enhancing Quality and Enabling
Innovation through Philanthropy
Year after year, we are left in awe of the commitment,
loyalty, and generosity of our volunteers. Without
this group of highly motivated and compassionate
people, we would not be able to support our eminent
researchers as they develop new strategies to
diagnose, prevent, and treat cancer.
We thank everyone who has answered the call to donate their time, money, and energy to this very worthy
cause. We are happy to report this past year’s fundraising efforts allowed many research projects — especially
those focused on personalized medicine — to move forward. The enthusiastic and charitable efforts of our donors
place the UCCCC in a position to advance its integrated scientific and clinical initiatives that focus on personalized
medicine over the next five years. With your help, philanthropy continues to be a driving force of our mission to
individualize cancer care.
Margaret Benjamin and Mary Ellen Connellan
Margaret Benjamin
President, Board of Trustees
The University of Chicago Cancer
Research Foundation
Mary Ellen Connellan
Executive Director
The University of Chicago Cancer
Research Foundation
The University of Chicago Cancer
Research Foundation (UCCRF) is a
not-for-profit organization founded
by Maurice Goldblatt in the 1940s to
support basic and clinical research
programs related to the treatment
and prevention of cancer at the UCCCC.
The UCCRF comprises four boards —
one governance board (Board of
Trustees) and three fundraising boards
(Women’s Board, Auxiliary Board,
and Associates Board).
Enhancing Quality and Enabling Innovation through Philanthropy
35

A Year in Review
Much of the research guiding personalized cancer care
at the UCCCC was made possible by the ongoing support
of philanthropy. The dedicated staff, active volunteers,
and generous donors of the University of Chicago
Cancer Research Foundation (UCCRF) worked tirelessly
for more than six decades to tap into their networks of
family, friends, and colleagues, raising more than $1.5 million
in fiscal year 2012 to advance personalized medicine.
The UCCRF Women’s Board allocated funds to support
the UCCCC’s Human Tissue Resource Center (HTRC),
which collects, stores, and distributes researchquality
human biospecimens for UCCCC investigators.
Over the past two years, the HTRC banked over
200,000 patient samples linked to demographic,

epidemiological, and clinical information. Access to this
data from large cohorts of patients is critical for developing
more effective personalized cancer treatment
and prevention strategies. The Board also supported
the creation of the UCCCC Personalized Cancer Care
Consortium (See page 23) to identify new approaches
for delivering personalized care, as well as efforts to discover
new therapeutic agents using research informatics
to benefit children diagnosed with neuroblastoma.
Among a variety of fundraising events, the Board raised
over $830,000 at their signature event, the 45th Annual
Cancer Ball.
The work of our talented researchers could not be
accomplished without the support of the UCCRF, which
provides critical start-up funds that are essential for
generating data to compete for federal research funding.
This year, the UCCRF Auxiliary Board supported
the work of three talented clinician scientists, including
Jill de Jong, MD, PhD, assistant professor of pediatrics,
Peter O’Donnell, MD, assistant professor of medicine,
and Michael Spiotto, MD, PhD, instructor of radiation and
cellular oncology, who are making strides in advancing
personalized cancer care. At one of several successful
events, The Board generated nearly $50,000 through
their “Leap of Faith” campaign, in which they wrote
letters to potential donors using the 2012 leap year to
emphasize the importance of an extra day for UCCCC
researchers to positively impact the lives of patients
with cancer.
The UCCRF Associates Board supported the UCCCC’s
Human Immunologic Monitoring-cGMP Facility, which
enables our researchers to conduct novel immunotherapy
clinical trials. By manufacturing therapeutic cancer
vaccines and measuring biological responses, the facility
plays a central role in developing new targeted immunotherapeutics
for cancer. The Board engaged donors at
several fundraising events this year, including the Valentine’s
Karaoke for a Cure and the Ham Jam, an afternoon
pig roast with friends and families, which together raised
nearly $10,000 in support of UCCCC research.
Philanthropy continues to forge the UCCCC’s groundbreaking
work in personalized cancer care.
From Left: Gordon Center
for Integrative Science, Gwen
and Jules Knapp Center for
Biomedical Discovery, Comer
Children’s Hospital
Enhancing Quality and Enabling Innovation through Philanthropy
37

UCCRF Board of Trustees
Margaret Benjamin
President
Thomas J. Duckworth
Vice-President
Barton G. Tretheway
Treasurer
Justin Ullman
Secretary
Mary Ellen Connellan
Executive Director
Members
John R. Atchison
James N. Bay, Jr.
Mrs. Seymour A. Cohen
Katherine Crouch
John W. Derse, Jr.
Mrs. Leonard S. Florsheim, Jr.
Wende L. Fox
Ruth Ann Gillis McGuinnis
Stanford J. Goldblatt
Charles P. Hammersmith, Jr.
Stephanie Harrold
Annette Hickman
Mrs. Michael Klein
John A. Kuhlman, Jr.
Debbie Madlener
Michelle McBride
Bruce Ovitz
Lori Ovitz
Jill Pollock
Suzanne Zaccone
Honorary Trustees
Seymour A. Cohen
Ronald L. Duitsman
Leonard Lavin
J. Clifford Moos
UCCRF Women’s Board
Jill Gosden Pollock
President
Laura Werner
Special Advisor
Becky Davidson
First Vice President
Mrs. David Nuelle
Second Vice President
Mrs. David H. Song
Treasurer
Nancy P. Stevens
Program Chair
Mrs. David W. Devonshire
Future Planning Chair and
Nominating Chair
Mrs. Joseph M. Brickman
Marketing & Communication
Mrs. Charles C. Harrold III
Board of Trustees Liaison
Mrs. Robert Conrad
Annual Appeal Chair
Ms. Wendy Chronister
Mrs. McKay McKinnon
Benefit Chairs
Members-at-large
of the Executive
Committee
Mrs. Brayton Bunn Alley
Mrs. John R. Atchison
Mrs. James Brady
Mrs. Henrik Clausen
Mrs. Benjamin Cox
Members
Mrs. William Adams IV
Mrs. Alexander Anagnost
Mrs. Helena Appleton
Allison Bacon
Mrs. James N. Bay
Margaret Benjamin
Mrs. Darcy Robert Bonner
Mrs. Harris C. Brumfield
Mrs. Michael Busch
Mrs. William R. Carney
Mrs. J. Rowan Carroll
Mrs. Benjamin D. Chereskin
Mrs. Gregory Chun
Mrs. Peter Clemens
Ruth A. Colby
Ms. Linda Burns Coleman
Mrs. Ann H. Cox
Mrs. Michael Crane
Mrs. J. Michael Crouch
Mrs. Richard W. Cusack
Mrs. Andrew Da Miano
Mrs. John Derse
Mrs. W. Brinkley Dickerson, Jr.
Ms. Nichole D’Aprile
Mrs. James F. Dugan
Marie Dzanis
Mrs. Donald Eugenio
Linda Finkel
Suzette Flood
Ms. Susan Florence
Mrs. Fahey Flynn
Mrs. David W. Fox
Mrs. Edward Gillette
Mrs. Thomas T. Hall
Mrs. Steven S. Helms
Lesli K. Henderson
Whitley Bouma Herbert
Mrs. William J. Hokin
Blaine Kinney Johnson
Shelley Johnstone Paschke
Robin Josephs
Mrs. Thomas Eric Kilcollin
Mrs. Donald A. King, Jr.
Kathy Kompare
Ms. Josephine Krug-Schulte
Mrs. J. Michael Luttig
Mrs. Andrew McGaan
Mrs. Edward J. Miller
Ms. Elissa Morgante
Yoko Kusama Mosher
Mrs. Stuart Oran
Ms. Jody Oshita-Bajor
Ms. M. Bliss Packer
Mrs. Kirby Pearson
Mrs. Heber Pierce
Diane Hutchinson Reilly
Mrs. David S. Rhind
Mrs. Frank C. Schell III
Mrs. James H. Schink
Barbara C. Sessions
Mrs. Gerald D. Skoning
Mrs. Andrew H. Slimmon
Mrs. J. Mikesell Thomas
Ms. Nancy Voss
Mrs. Keith Ward
Mrs. William Wardrop
Ms. Alice Williams-Verhoeven
Sustaining Members
Dr. Geraldine Balut Coleman
Mrs. Robert Alan Conger
Mrs. Jeffrey Diermeier
Mrs. Gustav Horschke
Mrs. Donald Horwitz
Mrs. Robert D. Kimball III
Mrs. Robert Kramer
Mrs. Donald Levinson
Mrs. Michael McGuinnis
Ms. Sandra Reese
Mrs. Harry J. Smedley, Jr.
Mrs. John C. Stone
Jennifer Kamp Tretheway
Honorary Members
Mrs. Walter E. Auch
Mrs. Wendy Becker-Payton
Mrs. Robert R. Bell
Mrs. Sharon Brix
Mrs. Seymour A. Cohen
Mrs. Leonard S. Florsheim, Jr.
Mrs. Margaret Laun-Knauf
Mrs. Arthur E. MacQuilkin
Ms. Cynthia Reusche
Mrs. Charles W. Tallent
Mrs. Charles Walgreen III
38

UCCRF Auxiliary Board
Annette Hickman
President
Laurie Baker Foster
Financial Liaison
Peggy Tieman
Secretary
Jan Gaines
Finance
Debbie Madlener
Foundation Liaison/
Membership
Magda Springuel
Julie Sullivan
Benefit Chairs
Georgia Heisinger
Midge Wegener
Auction Chairs
Lolly Roberts
Public Relations
Jackie Bossu
Reservation Chair
Midge Wegener
Sustaining Member Liaison
Active Members
Celeste Alcock
Elizabeth Brandt
Margo Calvetti Frost
Nancy Gupta
Terri Kingdom
April Krydynski
Kathy Mccarthy
Kari Roever
Wendy Schultz
Sustaining Members
Cindy Alston
Leigh Beith
Susan Bondurant
Barbara Bridges
Maggie Flanagan
Margaret Jacoby
Becky Kolleng
Joan Lancaster
Betty Ann Manganaro
Linda Mccann
Joann Mckibben
Andrea Montross
Helen Panje
Jan Peterson
Cathy Pratt
Mary Helen Ray
Tierney Sharif
Ginger Stambaugh
Patti Tyska
Mary Clare White
Liz Tunney Williams
Honorary Members
Cheri Allen
Barbara Devlin
Susan Fraley
Darlene Landsittel
Carol Lynnes
Patsy Mccurdy
Barbara Schmolze
Sharon Ubben
Chris Youngberg
UCCRF Associates Board
Katherine Crouch
President
Kate Cox
Vice President
Adam Simon
Treasurer
Laura Klement
Secretary
Members
Nicholette Andrews
Kristin Atchison
Darcy Bonner
Anika Clifton
Mallory DeHaven
Lindsay Essi
Margaux Harrold
Lesley Kompare
Katherine Kos
Sheila Mulligan
Chris Murphy
Ruthie Neumeier
Suzanne Nolan
Natalie Platt
Kimberly Pressling
Megan Ratliff
Ian Reither
Alex Reo
Concy Ridenour
Hilary Sargent
Michael Sullivan
Justin Ullman
Stephanie Werner
Enhancing Quality and Enabling Innovation through Philanthropy
planting the seeds of survivorship
39

Hi, I’m Natachie.
I’m a minimalist who enjoys the
simple things in life.
It’s amazing how good I feel now.
Natachie’s story
41

i’m a survivor
Natachie Goolsby was traveling to her family’s annual
reunion last July when she noticed pelvic pain and vaginal
discharge. Once home in Chicago, she saw a series of
doctors and underwent a variety of tests before receiving
the shocking diagnosis of advanced stage IV cervical
cancer, which had spread to her lymph nodes and bones.
At first, she couldn’t bring herself to tell her family members,
but they suspected something was wrong.
Then began what Natachie described as a rollercoaster
ride of emotions. When she finally came to terms with
her cancer diagnosis, she set her mind on what to do
next. The 64-year-old mother of four told her doctor,
“I’m going to fight it, with your help, because I have a lot
of things I want to do.”
Running out of standard treatment options, the radiation
oncologist and medical oncologist at Natachie’s local
hospital strongly recommended that she seek the help
of Ernst Lengyel, MD, PhD, professor of obstetrics and
gynecology, at the UCCCC. According to Dr. Lengyel,
Natachie faced a poor prognosis because her disease
was resistant to chemotherapy. However, given her
unusual clinical presentation and pathology, he decided
to test her for expression of human epidermal growth
factor receptor 2 (HER2), a protein that sends growth
signals to cancer cells and for which an approved
targeted treatment exists. Natachie tested positive,
providing a new therapeutic option. Dr. Lengyel sent her
to Gini Fleming, MD, professor of medicine, for treatment
with Herceptin (trastuzumab), to block the effects of
HER2, paired with Taxol (paclitaxel) chemotherapy. This
treatment combination is usually used in women with
aggressive HER2-positive breast cancer.
The tumor response was better than anyone anticipated.
The tumor shrunk significantly, and the lymph nodes
pushing on her neck melted away. Dr. Lengyel calls it
the miracle of personalized medicine when the tumor is
treated with agents that target its molecular signature;
Natachie calls Dr. Lengyel her angel for his encouragement
and his willingness to fight with her insurance
company to approve the treatment.

“My doctors at
the UCCCC
encouraged
They were like
my angels.”
— NATACHIE GOOLSBY
Natachie has noticed a big difference as her health
continues to improve. For example, she can now do her
own grocery shopping. She no longer feels pain in her
bones on every bump during car rides. She is back
outside gardening and fishing — things she once took for
granted before she got sick. The Southwest Chicagoan
also enjoys watching her grandchildren grow up.
“I tell them not to worry, that some things are out of our
control. We have to live with them as long as we can,”
she said, adding that people should never let a cancer
diagnosis stifle them to the point where they don’t want
to deal with it. “If you give up or give in, I don’t think
there’s much hope for you,” she said. “You have to fight.”
Looking Forward...
While UCCCC physicians have successfully used personalized
medicine to treat patients with cervical cancer,
they are also exploring combinations of chemotherapy
with concurrent radiation in clinical trials. For most cases
of locally advanced cervical cancer, patients are treated
with radiation combined with chemotherapy. Instead of
stopping chemotherapy after radiation, our physicians
continue to treat patients with adjuvant chemotherapy
in hopes of improving survival rates.
Natachie’s story
43

Our
Members
44

Expanding our Team
The UCCCC’s discoveries and innovations in cancer research and personalized
care are the result of highly collaborative efforts among our 210 accomplished
scientists and physicians. Each year, the UCCCC enlists new experts in basic and
clinical research to join our dedicated team. In fiscal year 2012, we welcomed
16 new members to strengthen our oncology programs.
Robert Chin, MD/PhD
Assistant Professor
of Radiation and
Cellular Oncology
Targeted cancer therapy
Jonas de Souza, MD
Instructor of Medicine
Cancer outcomes
and economics
Raymon Grogan, MD
Assistant Professor
of Surgery
Cancer biomarkers
Andrzej Jakubowiak,
MD/PhD
Professor of Medicine
Drug discovery
and clinical trials
Swati Kulkarni, MD
Associate Professor
of Surgery
Cancer prevention
Alexander Langerman, MD
Assistant Professor
of Surgery
Cancer diagnosis
and treatment
Hongtao Liu, MD/PhD
Instructor of Medicine
Cancer immunology
Yusuke Nakamura,
MD/PhD
Professor of Medicine
Cancer genomics
Aasim Padela, MD, MSc
Assistant Professor
of Medicine
Spirituality and medicine
Navin Pinto, MD
Instructor of Pediatrics
Personalized therapeutics
Yonglin Pu, MD/PhD
Associate Professor
of Radiology
Cancer imaging
Gordana Raca, MD, PhD
Assistant Professor
of Medicine
Cancer cytogenetics
Steffen Sammet, MD/PhD
Assistant Professor
of Radiology
Cancer imaging
and therapy
Manish Sharma, MD
Assistant Professor
of Medicine
Clinical trials
Fabrice Smieliauskas, PhD
Assistant Professor
of Health Studies
Clinical trials and
cancer economics
Xiaoyang Wu, PhD
Assistant Professor in
the Ben May Department
for Cancer Research
Cancer stem cells
our members
45

UCCCC Scientific
Programs Promote
Translational
Research
Figure 7. UCCCC Scientific Programs Promote Translational Research
The UCCCC plays a central role in coordinating the
University of Chicago Medicine’s activities in cancer
research, patient care, education, and community outreach.
Our members, who specialize in all fields of cancer
research, are organized into six scientific programs that
focus on basic, clinical, and population research. These
programs are complementary and promote collaboration
among our diverse team of scientists and physicians
who are committed to translating research to new diagnostic
tests, more effective therapies, and interventions
to prevent cancer.
MOLECULAR MECHANISMS
OF CANCER PROGRAM
BASIC
SCIENCES
ADVANCED IMAGING
PROGRAM
IMMUNOLOGY AND
CANCER PROGRAM
HEMATOPOIESIS AND
HEMATOLOGICAL
MALIGNANCIES PROGRAM
POPULATION
SCIENCES
CLINICAL/
TRANSLATIONAL
SCIENCES
CANCER
PREVENTION
AND CONTROL
PROGRAM
PHARMACOGENOMICS
AND EXPERIMENTAL
THERAPEUTICS PROGRAM
46

Raising Our Prestige
The UCCCC has long been recognized as a leader in basic and clinical research, particularly for our contributions in
the characterization of hematological malignancies such as leukemia, the development of new therapies for head
and neck cancer, tumor immunology, and cancer genetics. In the last decade, we have gained international recognition
for our personalized oncology programs, particularly in identifying patients at high risk for cancer and predicting
response to cancer drug therapies. Our members are bestowed prestigious awards in recognition of these and other
efforts that have brought the UCCCC to the forefront of cancer research. Below is a sampling of distinguished honors
highlighting our members’ contributions toward improving patient care.
Susan Lerner Cohn, MD
Treasurer of the American Society
of Clinical Oncology
Michelle M. Le Beau, PhD
Vice President/President-Elect, Association
of American Cancer Institutes
Member of the Board of Directors of the
American Association for Cancer Research
Olufunmilayo Olopade, MBBS
American Association for Cancer Research 2011
Distinguished Lecture on the Science of Cancer
Health Disparities
Janet D. Rowley, MD, DSc
Ernest Beutler Prize from the American Society
of Hematology
Japan Prize for Healthcare and Medical Technology
Michael Maitland, MD, PhD
Leon I. Goldberg Young Investigator Award
from the American Society for Clinical Pharmacology
and Therapeutics
Richard L. Schilsky, MD
Fellow of the American Society of Clinical Oncology
David Rubin, MD
Rosenthal Award for Patient Support and Care from the
National Crohn’s and Colitis Foundation of America
Lucy Godley, MD, PhD
Elected Member of the American Society
of Clinical Investigation
University of Chicago campus
our members
47

Figure 8. UCCCC by the Numbers, 2011
#1
6200
526
323
320
210
RANKED U.S. NEWS & WORLD REPORT
CANCER HOSPITAL IN ILLINOIS*
105
#15
RANKED U.S. NEWS & WORLD REPORT
CANCER HOSPITAL IN THE NATION*
NEW CANCER PATIENTS
PEER-REVIEWED CANCER-
RELATED PUPLICATIONS
PEER-REVIEWED CANCER-
RELEVANT GRANTS
THERAPEUTIC
CLINICAL TRIALS
UCCCC MEMBERS
HOSPITAL BEDS DEDICATED
TO CANCER PATIENTS
*Current Ranking

vital statistics
Figure 9. Peer-Reviewed Cancer Research Grants
Awarded to UCCCC Members in 2011
$41,977,254
OTHER NATIONAL
INSTITUTES OF
HEALTH
$69,169,902
PEER-REVIEWED CANCER RESEARCH GRANTS
AWARDED TO UCCCC MEMBERS IN 2011
$396,859
NATIONAL SCIENCE
FOUNDATION
$4,670,423
OTHER PEER-REVIEWED
$1,113,299
AMERICAN
CANCER SOCIETY
$21,012,067
NATIONAL
CANCER INSTITUTE
Figure 10. Patients Enrolled in UCCCC Therapeutic Clinical Trials by Disease Site in 2011
19
SKIN
22
7
20
THYROID
SOFT TISSUE
BRAIN AND
NERVOUS SYSTEM
73
PROSTATE
60
174
ADVANCED
SOLID TUMORS
LUNG AND
MESOTHELIA
104
876
PATIENTS ENROLLED
IN THERAPEUTIC
CLINICAL TRIALS
HEAD
AND NECK
6
OTHER
142
LEUKEMIA, LYMPHOMA
AND MULTIPLE MYELOMA
16
CERVIX, UTERUS,
OVARY AND
FALLOPIAN TUBE
93
STOMACH, PANCREAS
AND LIVER
28
18
COLORECTAL
KIDNEY, BLADDER
AND URINARY TRACT
94
BREAST
UCCCC by the Numbers
Addressing cancer from every angle, the UCCCC is
committed to bringing patients new hope through
laboratory research, innovative clinical trials, and
population research to prevent cancer. Our successes
(see Figure 8) rely on the synergy between scientists
and physicians who are dedicated to translating our
scientific breakthroughs to state-of-the-art patient care.
Cancer Research Grants Advance
Personalized Medicine
Scientific discoveries and their translation from bench
to bedside require significant investment. In 2011, our
researchers received nearly $70 million in competitive
peer-reviewed grant funding from the government and
private sector to support 323 cancer research projects
(see Figure 9).
Offering Innovative Therapies
The UCCCC is a national leader in the development
of clinical trials to test new anti-cancer therapies. Our
drug development program is unique in the Chicago
metropolitan area and is among the largest in the
United States. Basic scientists work closely with translational
and clinical researchers to conduct clinical
trials with a strong focus on personalized therapeutics.
Many of our trials incorporate pharmacogenomics, which
evaluates how genetics influence drug response. Each
year, the UCCCC treats 800-900 patients (see Figure 10),
who travel from throughout the world, on therapeutic
clinical trials.
vital statistics
49

Financial
Report
50

Financial Chart 1: Income
beginning balance $2,484,415
Income
UCCRF Contributions $299,345
UCCRF Capital Campaign $447,817
Boards/Auxiliaries $959,966
Women’s Board Campaign $1,000
Endowment Income $77,235
Income
4%
ENDOWMENT
INCOME
0.1%
WOMEN’S BOARD CAMPAIGN
54%
BOARDS/AUXILIARIES
Total Income $1,785,363
Expenses
Financial Chart 2: Expenses
Operating
Personnel $342,478
Services $304,553
Supplies $4,594
Total Operating $651,625
Allocations
Research & Faculty Support $217,324
Women’s Board $600,000
Auxiliary Board $54,000
Associates Board $12,000
Capital Campaign $450,000
Total Allocations $1,333,324
Expenses
33%
OPERATING
67%
ALLOCATIONS
Total Expenses/Allocations $1,984,949
Ending Balance $2,284,829
Period from 7/1/11–6/30/12
Financial report
51

2011–2012
DONORS
52

We gratefully acknowledge those who have generously supported cancer
research, clinical care, and patient-related services. Thank you for helping the
UCCCC advance our mission to prevent cancer and personalize patient care.
The following alumni, friends, foundations, and corporations have demonstrated
their extraordinary loyalty and commitment through their gifts. These gifts
include cash, matching gifts, securities, pledges, and pledge payments received
July 1, 2011–June 30, 2012.
Director’s
Leadership Circle
$1,000,000+
American Cancer Society, Inc.
Anonymous
Dr. Ralph and Marian Falk
Medical Trust
Jim and Karen Frank
Diamond Circle
$250,000 – $999,999
Abbott
Mr. Grant Achatz
American Cancer Society
Illinois Division, Inc.
Avon Foundation
The Breast Cancer
Research Foundation
Cancer Research Foundation
Cooney and Conway
Entertainment Industry
Foundation
Foglia Family Foundation
Gabrielle’s Angel Foundation
for Cancer Research
Vivian G. Johnston, III, Esq
Mr. Nicholas Kokonas
Susan G. Komen
Breast Cancer Foundation
Leukemia & Lymphoma Society
Virginia & D.K. Ludwig Fund
for Cancer Research
Ben May Charitable Trust
Kenneth E. Niemeyer
The Ovarian Cancer Research
Fund, Inc.
Dr. Martin Perlman
Searle Funds at The Chicago
Community Trust
St. Baldrick’s Foundation
UCCRF Women’s Board
Sapphire Circle
$100,000 – $249,999
Alex’s Lemonade Stand
Foundation
Anagen Therapeutics, Inc.
Anonymous
Blum-Kovler Foundation, Inc.
Burroughs Wellcome Fund
Cancer Research Institute
Connelly & Vogelzang, LLC
Mr. William Connelly
Mr. Kevin J. Conway and
Mrs. Linda J. Conway
Mr. and Mrs. John D. Cooney
Mrs. Loretta W. Cooney and
Mr. Robert J. Cooney
Thomas J. Duckworth and
Connie Duckworth
Enivar Charitable Fund
Mrs. Kathleen R. Fahey and
Mr. William R. Fahey
Fanconi Anemia Research
Fund, Inc.
Flight Attendant Medical
Research Institute
Mr. and Mrs. Richard A. Gonzalez
John D. & Barbara C. Cooney
Family Foundation
The Lisa Klitzky Foundation
The Francis L. Lederer
Foundation
Michael Rolfe Pancreatic
Cancer Foundation
Katherine Griem and
Anthony Montag
Partnership for Cures
Mrs. Allison Peebles and
Mr. John D. Peebles
Mrs. Linda Quasney
Robert J. & Loretta W. Cooney
Family Foundation
Ms. Elizabeth R. Smith and
Mr. Gordon Smith
Damon Runyon-Walter
Winchell Cancer Fund
Segal Family Foundation
Mrs. Carole Browe Segal and
Mr. Gordon I. Segal
The Simmons
Mesothelioma Foundation
The V Foundation for
Cancer Research
Mr. Nicholas J. Vogelzang, Jr.
William Guy Forbeck
Research Foundation
Zaccone Family Foundation
Ruby Circle
$50,000 – $99,999
American Society of
Clinical Oncology
Association of American
Cancer Institutes
Bears Care Foundation
Boston Scientific Corporation
Estate of Marie Eileen Bratu
Mildred and Marv Conney
FJC A Foundation of
Philanthropic Funds
Alvin H. Baum Family Fund
Mr. Richard K. Mullin and
Ms. Mary J. Henry
Janice Lamb McArdle Cancer
Research Foundation
Ronald and Sondra Katz
The Helen and Bernard Kozloff
Family Foundation
Lung Cancer Research
Foundation
Mr. Jeffrey Morgan and
Ms. Valerie Morgan
Neuroblastoma Children’s
Cancer Society
Cancer Research and
Prevention Foundation
Project Ladybug
Prostate Cancer Foundation
Shire Pharmaceuticals
Mr. and Mrs. John B. Snyder
Supera Family Foundation
UCCRF Auxiliary Board
Platinum Circle
$25,000 – $49,999
Bear Necessities Pediatric
Cancer Foundation
The Wendy Will Case
Cancer Fund, Inc.
Mr. and Mrs. Benjamin Chereskin
Cox Family Foundation
Crohn’s & Colitis Foundation
of America, Inc.
Craig and Janet Duchossois
Foundation for Informed Medical
Decision Making
Guy Geleerd Memorial
Foundation
Mr. James D. Geleerd
Mrs. Judy Geleerd-Kitzes
Howard Hughes Medical Institute
I-I District Kiwanis International
Spastic Paralysis Researh
Impath, Inc.
Intuitive Surgical, Inc.
Estate of Cynthia Sue Juby
Ms. Rita Meltzer
Mr. and Mrs. Greg Moss
National Health
Research Institute
Mr. and Mrs. John Paleczny
Peggy Spiegler Melanoma
Research Foundation
Mr. David N. Phelps
Michael Reese Health Trust
Respiratory Health Association
of Metropolitan Chicago
Riviera Country Club and
Sports Center
Mrs. Marlene Rumbach
Mr. Martin G. Solomon and
Mrs. Sue Solomon
Neil Spiegler
Valda and Robert Svendsen
Foundation
THANC Foundation, Inc.
Mrs. Harry Woldenberg
Gold Circle
$10,000 – $24,999
Mr. and Mrs. Brayton B. Alley
John W. Anderson Foundation
Mr. and Mrs. Bruce Anderson
Anonymous (2)
Arlington Million Ladies
Avotec Incorporated
J. Douglas Bacon and
Allison Bacon
Mr. and Mrs. James N. Bay, Jr.
Mr. and Mrs. Lawrence Benjamin
William Blair & Company
Harry F. and Elaine Chaddick
Foundation, Inc.
Chicago White Sox Charities, Inc.
Mr. Stanley D. Christianson
Tricia and Benjamin Cox
D. B. Alley Ovarian Cancer
Research Foundation
Mr. and Mrs. David W. Devonshire
Mr. Richard and
Mrs. Judi Duchossois
2011–2012 donors
53

Exelon Corporation
Mr. Marc Feliciano and
Mrs. Carolyn Pleyto-Feliciano
Fidelity Charitable Gift Fund
Ms. Jane Haverstock
The Grover Hermann Foundation
Trust Estate of Louis L. Joseph
Katten Muchin &
Zavis Foundation, Inc.
Mrs. Elisabeth F. Lanzl
Andrea and Benjamin Leshem
Merchandise Mart Properties
Mr. William J. Meyer
Ms. Maria L. Myrianthopoulos
National Material L.P.
NBC Universal
Petersen Aluminum Corporation
Polo Ralph Lauren
Mrs. Cynthia M. Reusché
Riding For a Cure
Sherwin and Natalie Rosset
Mr. Anthony Santacroce
Mr. Harvey Schaffer
Mr. Charles G. Schultz
Mr. and Mrs. Rex Sessions
Mr. Michael Tang
The Dennis Ferguson
Cancer Research Fund
UBS/Painewebber, Inc.
UCB Inc.
UCCRF Associates Board
University of Illinois Foundation
Mr. John Waller and
Mrs. John Waller
Wells Fargo Foundation
Ms. Eleni Vlahos-Yianas and
Mr. Constantinos Yianas
Silver Circle
$5,000 – $9,999
Mr. J. Todd Arkebauer
Mr. Peter Bajor and
Mrs. Jody Oshita-Bajor
Modestus Bauer Foundation
Mr. and Mrs. James Bozik
Mr. and Mrs. Thomas Brady
Mr. James F. Brady and Mrs.
Terese Eckelkamp-Brady
Trust Estate of Saramae Braun
Mrs. Alisoun D. Brewster and
Mr. Stephen Brewster
Estate of Lillian Z. Bronkhurst
Mr. Zachary B. Bulwa
Ms. Kim Callaghan and
Mr. Michael Callaghan
Cantor Fitzgerald Relief Fund
Mr. Henrik and Mrs.
Annemette Clausen
Crain Communication, Inc.
Cure It On The Court
Mr. and Mrs. Andrew Da Miano
Deutsche Bank Americas
Foundation
Nancy Dugan, MBA’97 and
James Dugan
The Duk Young Foundation
Mrs. Rose Geraci
Maurice H. Givens
Charitable Trust
Mr. Bruce Leigh Goldsmith
Mr. Tim French and
Ms. Jo L. Haley
Mr. and Mrs. Steven S. Helms
Mr. Ray Holloway
Ms. Josephine M. Krug and
Mr. Gerard Schulte
Mr. William J. Krug and
Ms. Marta Ramirez Krug
Laini Fluellen Charities
Lazzara Family Foundation
Judy and Wayne Lewis
Mr. Andrew L. McGaan and
Ms. Pamela L. McGaan
Mr. and Mrs. Michael J. McGuinnis
Mr. Peter A. McLean
Moneris Solutions, Inc.
Mr. J. Clifford Moos
Mr. Stephen D. Nechtow
Mr. Eric Ng
John Nuveen & Co. Incorporated
Mr. Gregory P. Richards
Mr. Paul Rubschlager and
Mrs. Joan Rubschlager
Mr. and Mrs. Robert Swartz
Ms. Suzan W. Swartz
UCCRF Associates Board
Mr. Donald L. Ullman and
Mrs. Marilyn Ullman
Verta Richards Foundation
Pancreatic Cancer
Mr. and Mrs. Michael Werner
Dr. James Williams
Winston & Strawn
Bronze Circle
$2,500 – $4,999
Mr. David Achatz
Mr. and Mrs. William Adams IV
Mr. Glenn P. Albert, Jr.
All About Pink
Breast Cancer Foundation
John Amboian, AB’83, MBA’84
and Ann Lee Amboian, AB’83
Mrs. Alexander Anagnost
Mr. Richard Alan Angell and
Mrs. Julie Angell
Mr. and Mrs. Anthony
J. Augustine
Ms. Rosemary Bacovsky
Dr. and Mrs. John H.
Beckerman III
Mrs. Judy Bednar and
Mr. Mark Bednar
Friends of the
Biological Sciences
Mr. David A. Helfand and
Ms. Leslie N. Bluhm
Darryl M. Bronson, MD
Mr. Jordan Bulger
David Callahan, AB’87
Mr. James W. Chamberlain
Mr. Igor Chernomzav
Mr. and Mrs. Peter Clemens
Mr. David Cooney and
Mrs. Peg Cooney
Patricia O. Cox
Mr. Michael Davitt
Mr. and Mrs. Steven Deli
Mr. Constantine Djedjos
Mr. Charles Dudley
Ms. Carol K. Dugan
D.J. Edelman Family Foundation
Mr. Gable Edmisten
Mr. William Eiserman
Ms. Stephanie Fields
Ms. Amanda Friedeman
The Thomas and Jerrice Fritzlen
Family Charitable Fund
Dr. Leslie Gable and
Ms. Hazel Fisher-Gable
Ms. Jan Gaines
Mr. Ryan Matthew Garino
Mr. Vincent Gee
Ms. Katherine Gorham
Mr. Jonathan Graham
Ms. Lisa Hale
Mr. and Mrs. Robert A. Helman
Frances Henkel and
Michael Henkel
Mr. Charles Hetzel
Ms. Sarah Hetzel
Mr. Jamie Hine
Mr. Austin L. Hirsch and
Ms. Beth Gomberg-Hirsch
Mr. and Mrs. Howard Hoffmann
Mr. Chris Jensen
Ms. Susan Joenck
Mr. Scott Judy
Junior Cancer League
Ms. Kristine Kelly
Mr. Philip Dixon Kepler and
Mrs. Lisa M. Kepler
Mr. Irvin Kessler
Mr. Marty Klein
Mr. Robert Kolitz
Ms. Aimee Koski
Mr. Ory Kushnir
Mr. Joseph Lachman
Mr. and Mrs. Alan A. Lazzara
Ms. Khoa Le
Mr. Jonathan Lehman
Mr. Laurence Lewis
Ms. Jessica Liotta
Mr. and Mrs. Kenneth Love
Mr. Eric Lunt
Mr. James MacDonald
Mr. Peter McCarthy
Ms. Erika Melchiorre
Mrs. Edward J. Miller
Karol J. Moller
Montini Catholic High School
Mr. Fred Wilson and
Ms. Elissa Morgante
Mr. J. William Nelson
Mr. Brien O’Brien
Ms. Maureen O’Brien
Mr. Paul Philbrick
Lisa and Mark Pinsky
Mr. Joshua J. Prangley and
Mrs. Karin Prangley
Mr. Jeffrey J. Quasney
Mr. John R. Raitt and
Ms. Mary M. Raitt
Richard/Carolyn Blum
Charitable Foundation
Dr. Mark Richter
Mr. Stuart Rosen
Saddle & Cycle Club/
Calcutta Tennis Tournament
Mr. Marcel Schellekens
Mr. and Mrs. Robert G. Schloerb
Mr. Michael Schubmehl
Mr. Matthew Arthur Schuchardt
Mr. Rhett Silver
Mr. Brian Sisitzky
Mr. Jason Sissel
Ms. Katherine Smith
Dr. David Song and
Mrs. Janie Song
Mr. David Spector
Mr. Zak Tamsen
The O’Malley Family Fund
Mr. and Mrs. J. Mikesell Thomas
Townsend Family Foundation
Mr. and Mrs. Barton G. Tretheway
Ms. Ann Van Meter
Vanguard Charitable
Endowment Program
Mr. and Mrs. William S.
Wardrop, Jr.
Mr. Eugene Wei
Mr. James M. Weichselbaum and
Ms. Susan L. Weichselbaum
Ms. Cynthia Yeung
Founders
$1,000 – $2,499
Dr. Kris and Mrs. Trisha
Rooney Alden
Miriam Alsikafi and
Mr. Zaid Alsikafi
Dr. and Mrs. Milton D. Alter
Mr. and Mrs. Robert O. Anderson
Aileen S. Andrew Foundation
Anonymous (3)
Ms. Robin Pierce Armour
Mr. and Mrs. John R. Atchinson
Kelley Gramm Audrain and
Paul C. Audrain
Ms. Anne E. Bagan
Mr. Harold K. Baldwin and
Katherine Wood Baldwin
Dr. Donald G. Ball
Mr. Christopher Barber and
Ms. Katherine A. Barber
Dr. Richard L. Baron
Mr. and Mrs. Douglas Batchelor
Baxter International Foundation
Mrs. Renee Belman
Ms. Bonnie J. Benson
Marta Bonner and
Darcy Robert Bonner
Mr. Stephen K. Bossu and
Ms. Jacquelynn H. Bossu
Mr. and Mrs. Russell Brandstetter
Mr. and Mrs. Joseph M. Brickman
Mr. and Mrs. David Brint
Dr. Jerome J. Brosnan
Ms. Ruth E. Bruch
Mr. and Mrs. Harris C. Brumfield
John and Jackie Bucksbaum
Dr. Kenneth Buckwalter
Ms. Ann T. Burgess
Ms. Emanuela Z. Carney and
Mr. William Carney
Annette Carroll, MBA’85 and
J. Rowan Carroll, MBA’96
Dr. Pierre-Andre Chiappori and
Dr. Kristina Orfali
The Chicago Community Trust
Mr. and Mrs. John F. Chizmar
Linda Burns Coleman and
Neil Coleman
Mrs. Andrea M. Conant and
Mr. C. Christopher Conant
Mary Ellen and
Kevin A. Connellan
Mr. and Mrs. Robert L. Conrad
Mr. Michael Corey
Mr. and Mrs. Michael E. Crane
Crown Corr, Inc.
Ms. Helen B. Daigle
Mr. and Mrs. Kirt Hayes
Mrs. Laura Sims Davis
Mrs. Nancy R. Davis and
Mr. Richard J. Davis
Ms. Christine Dawson and
Mr. Daniel Dawson, Jr.
Mrs. Herta A. Dech and
Dr. Ludwig Dech
Mr. Gilles Demeulenaere and
Neeta Demeulenaere
Mr. William G. Dempsey

Mr. and Mrs. John W. Derse, Jr.
Mr. Brian Dettmann and
Ms. Kelly A. Dettmann
Dr. Peter E. Doris
Dovenmuehle Mortgage, Inc.
Patricia J. DuCanto and
Joseph N. DuCanto, JD’55
Mr. and Mrs. Richard F. Duffy
Mr. and Mrs. Ronald L. Duitsman
Ms. Sheryl L. Dyer
Mr. and Mrs. Donald Eugenio
Mr. Dean Facatselis and
Mrs. Kay Facatselis
Mr. and Mrs. Fred Feinstein
Dr. John J. Fennessy
Mr. and Mrs. Robert Finkel
Mr. and Mrs. Paul J. Finnegan
Dr. and Mrs. Timothy Flood
Mr. and Mrs. David W. Fox, Jr.
Ms. Wende L. Fox and
Mr. L. James Lawson III
Mr. Christopher J. Fraleigh
Fresh Ideas Clothing Company
Mr. and Mrs. Timothy W. Frost
Mr. Peter Gaido
Mr. and Mrs. James Gelbort
Ms. Margaret Ghering
Laura and Edward Gillette
Karla S. Gillette and
Edward S. Gillette
Mr. Ted Goergen
The Family of William B. Graham
Ms. Jodi Groen
Mr. and Mrs. Raj P. Gupta
Mrs. Nancy G. Haller and
Mr. Gene Haller
Mr. and Mrs. Charles C. Harrold III
HEB Foundation
Mr. Charles Heftman and
Ms. Mary Pat Heftman
Ms. Georgia Heisinger
Mrs. Patricia A. Hastings-
Henderson and Mr. Craig
W. Henderson
Ms. Annette Hickman
Angie Holleb and
Thomas Holleb, MBA’98
Mr. Arthur Holstein IV and
Mrs. Lisa Holstein
Mr. and Mrs. Roger F. Hruby
Mr. Michael Hughes
William B. and
Melanie S. Hummer
Mr. and Mrs. Timothy Hurd
John and Jacolyn Bucksbaum
Family Foundation
Mr. and Mrs. Rob Johnson
Blaine Kinney Johnson
Mr. and Mrs. Roger B. Johnston
Mr. David Katz and Ms. Karie Katz
Ms. Carol W. Keenan
Mr. and Mrs. William S. Kies, Jr.
Mr. and Mrs. Thomas E. Kilcollin
Mr. Richard D. Kincaid and
Ms. Jackie Kincaid
Mr. Charles A. Kinder and
Mrs. Kristine R. Kinder
Ms. Therese G. Kingdom
Barbara Malott Kizziah and
Keith Kizziah
Marlowe and David Klitzky
Paul Knapp, MBA’77 and
Nancy Knapp
Ms, Stephanie Knight and
Mr. Tim Knight
Mr. Mark Koehler
Dr. Stephen Kron and
Dr. Elizabeth M. McNally
Mr. and Mrs. Larry Krueger
Ms. April M. Krydynski
Dr. Richard Kubota
Ms. Susan A. Kuzelka
LaCosta, Inc.
Dr. Michelle M. Le Beau and
Dr. Robert Harwood
Mr. Chase C. Levey
Russell Levine, JD’86
Mr. Michael R. Levinson and
Ms. Cara B. Levinson
Julius Lewis
Mr. and Mrs. John S. Lillard
Ms. Elizabeth A. Luttig and
Mr. J. Michael Luttig
Mr. Cary Malkin and
Mrs. Lisa Malkin
Karen Manzari and Tony Manzari
Dr. and Mrs. James E. Marks
Mr. and Mrs. James F. Martin
Mr. Martin E. Martinson and
Mrs. Monica Martinson
Mr. and Mrs. Thomas Marziani
Dr. and Mrs. McKay McKinnon
MedNet Solutions, Inc.
Mr. and Mrs. Stephen Meskan
Mr. and Mrs. Charles L. Michod, Jr.
Mr. and Mrs. Robert Johns Mignin
Mr. Michael M. Mitchel
Ms. Amy Fairbanks Morro and
Mr. William C. Morro
Mr. and Mrs. William Mynatt
National Philanthropic Trust DAF
Ms. Amy M. Neill
Mr. and Mrs. David Nuelle
Mrs. Amanda Nunnink and
Mr. Brandon Nunnink
Claire O’Grady and Michael
O’Grady
Ms. Joan O’Malley
Packard Research Foundation
Mr. and Mrs. Lyle E. Packard
Ms. Mary B. Packer
Mr. and Mrs. Brett Paschke
Mr. and Mrs. Kirby Pearson
Debra and Robert Peterson
Jill Pollock and Gordon Lee
Pollock, MBA’73
Dr. and Mrs. Ronald B. Port
Dr. Mitchell Posner and
Mrs. Janice Posner
Mr. Steffan Postaer and
Susan Postaer
Ms. Niki Quasney and
Ms. Amy Sandler
Ms. Susan P. Quasney
Dr. Brian Randall and
Dr. Mary C. Kemen
Red Bird Hollow Foundation
Ms. Kari Rekoske
Renaissance Charitable
Foundation, Inc.
Jennifer and David Rhind
The Rhoades Foundation
Mr. Robert Rickett and
Mrs. Robert Rickett
Mr. James L. Rosenbloom
Dr. Marsha Rosner and
Dr. Robert Rosner
Kevin P. Ryan, DDS, PC
Mr. Charles A. Saager and
Ms. Theresa Saager
Mr. Joseph D. Sabol and
Ms. Lisa A. Sabol
Saks, Inc.
Mr. David L. Saloom
Mr. Scott Sauer
Mr. and Mrs. Frank
Charles Schell III
Mr. and Mrs. James Schink
Ms. Martha E. Schmidt
Ms. Patricia Schmidt and
Mr. Theodore Schmidt
The Schwab Fund for
Charitable Giving
Alan & Roslyn Schwartz
Foundation
Mr. and Mrs. Rob Selati
Arch W. Shaw Foundation
Ilene Warshawsky Shaw, AM’75
Ms. Jean E. Sheridan
Mr. Lloyd Shoen
Mr. and Mrs. Michael L. Silver
Mr. and Mrs. Gerald D. Skoning
Karen Slimmon, MBA’91 and
Andrew Slimmon, MBA’91
Donna Speigel
Ms. Roslyn Spellman
Ms. Magda Springuel
St. Jude Children’s
Research Hospital
Veronika A. E. Steingraber and
Fred G. Steingraber, MBA’64
Ms. Nancy P. Stevens
Bolton Sullivan Fund
Mr. and Mrs. Timothy P. Sullivan
Mr. Michael Svets and
Mrs. Michael Svets
Mr. and Mrs. John Svoboda
Mr. Kenneth Tucker
United Way of
Metropolitan Chicago
Mr. and Mrs. Joseph M. Valerio
Ms. Nancy Voss
Mr. and Mrs. Keith Ward
Wein Family Foundation
Mrs. Andrea Wilson and
Mr. Reading Wilson, Jr.
Mr. and Mrs. Patrick Winters
Ann S. Wolff
Benefactors
Under $1,000
Mr. Joel Aarons
Mr. Craig Abbott
Mrs. Audrey L. Abraham and
Mr. Robert L. Abraham
Darrow Abrahams
Ms. Michelle Abrahamson
Mr. and Mrs. James D. Abrams
Ms. Wendy Abrams
Mr. Bradley Lorin Abramson and
Mrs. Sharona L. Abramson
Mrs. Shirley E. Abramson and
Mr. Sidney Abramson
Ms. Julie B. Ackerman
Adams Magnetic Products
Mrs. Betty J. Adams
Barbara Stolberg Adelman,
AB’70, MBA’76 and
Steven Adelman
Mrs. Debora P. Aghion and
Mr. Victor Aghion
Ms. Mary Beth Airsman and
Mr. Teryl E. Airsman
Ms. Nancy E. Akerley
Mrs. Celeste Alcock and
Mr. Kevin Alcock
Mr. Frank J. Alexander and
Mrs. Valerie R. Alexander
Ms. Wendi Alexander
Ms. Betty M. Algaier
Dr. Shehzad Ali
Mr. Donald Allen and
Mrs. Evelyn Allen
Mr. Lloyd Allen and
Mrs. Ruby Allen
Allied Pilots Association
Allstate Foundation
Almeida Family Foundation
Mr. and Mrs. Richard Almeida
Mrs. Cynthia C. Alston and
Mr. Martin G. Alston
Alternative Reproductive
Resources
Ms. Linda L. Altheide
Mrs. Helen Andersen
Ms. Colleen Anderson and
Mr. William Q. Anderson
Mr. Collin Anderson
Mr. Harry L. Anderson and
Mrs. Lois M. Anderson
Ms. Nicholette Andrews
Mrs. Sally J. Andrews and
Mr. William C. Andrews III
Mrs. Connie M. Andrus
Ms. Leticia G. Angelo
Mr. Stephen R. Poma and
Ms. Margaret Elizabeth Annett
Mrs. Loretta Annex and
Mr. Terry Annex
Anonymous (3)
Mr. Louis Antonelli
Mr. Gregory Antonucci and
Mrs. Jenine M. Antonucci
Mr. Dave Apter and
Ms. Susann T. Apter
ArcelorMittal
Dr. Maureen K. Archambault
Ms. Eugenia A. Arger
Argonaut Group, Inc.
Mr. Steve Arnold and
Ms. Tammy Arnold
Mr. Steven Arnstein
Mr. Andrew J. Aronson and
Mrs. Lisa L. Aronson
Ms. Lisa B. Aronson and
Mr. Tom Aronson
Ms. Patricia A. Arvio
Marlena Ascher
Mrs. Michele Aspan and
Mr. Rick Aspan
Mrs. Carolyn Axt and
Mr. Donald Axt
Ms. Jeannie M. Bachner
Charlene Baizer
Ms. Frieda Baker
Mr. Barry S. Baldwin
Mrs. Paula Ball
Ms. Lyn Ballard
Mr. Fiyinfolu O. Balogun
Mr. Bruce Balonick and
Ms. Marcia Balonick
Ms. Cindy Bandur and
Mr. Stanley R. Bandur
Bank of America United
Way Campaign
Mr. Peter J. Barack
Ms. Tammy Baranowski
Ms. Carol Baranski
Ms. Janelle Barcelona
Mrs. Carol B. Bargmann and
Mr. Clyde B. Bargmann
Robert E. Barker, DDS, PC
Ms. Shari Barker
Susan Kay, AM’79 and David
Baron, AB’72, PhD’79
2011–2012 donors
55

Ms. Therese Barrett and
Mr. Steven E. Burkholder
Donna Bass
Mr. Edward L. Bass and
Ms. Kimberly S. Bass
Mr. Donaldo Batiste
Mr. and Mrs. Bernard M. Baum
Mr. Arthur R. Baumgarten and
Mrs. Eileen Baumgarten
Ms. Heather Baundgaard
Mr. Brant Baxter and
Ms. Kimberly Baxter
Mr. Bruce Becker and
Ms. Denise Becker
Ms. Denise C. Becker and
Mr. Terence M. Becker
Mrs. Anna Beederman and
Mr. Daniel E. Beederman
Mr. Fred Begy and
Mrs. Marianne Begy
Mr. Andrew E. Bej and
Mrs. Natalie S. Bej
Mr. Michael Belcher
Mrs. Robert R. Bell
Ms. Frances Gurwin Bell
Ms. Margaret Belliel
Mr. Hakeem A. Bello and
Mrs. Olufolasade O. Bello
Mr. Keith Bellof
Belmont Trading Company
Ms. Mary C. Belton and
Mr. Terrence Belton
Mr. Bruce A. Bendoff and
Mrs. Judith D. Bendoff
Mr. David W. Bene
Ms. Claire L. Bentley
Ms. Gwen Bergman
Mr. John Beringer
Mr. Jeffrey Berke
Mr. Bruce A. Berman and
Mrs. Rebecca L. Berman
Mrs. Sallie M. Bernard and
Mr. Thomas Bernard
Dr. and Mrs. Joel R. Bernstein
Dr. Mark Bernstein and
Dr. Louise Parker
Ms. Joanne Bernstein and
Mr. Robert J. Bernstein
Ms. Laurie A. Bersztaitis
Mr. Frank Bertone
Ms. Theresa Bertucci
Mr. Larry G. Bettcher and
Ms. Susan L. Bettcher
Ms. Bessie C. Betzelos
Mr. Howard Bifeld
Ms. Kathleen A. Biron
Mr. Jay Bishov and
Ms. Lois Bishov
Mr. and Mrs. C. Edward
Bjorncrantz
Ms. Linda M. Black and
Mr. Richard J. Black
Mr. Frank H. Blackmore and
Mrs. Judith Blackmore
Mr. Justin P. Blackstone
Blackwell/Aleshire, Inc.
Mr. Donald Blangin
Mr. Daniel Blankenship and
Mrs. Nelda D. Blankenship
Mrs. Irene Blitt and Mr. Leon Blitt
Ms. Linda Block
Mr. Alan Blomquist
Ms. Natalie Ann Bloodgood
Andrew H. Bloom and
Alison S. Bloom
Ms. Sarah Blue
Ms. Elizabeth B. Blum and
Mr. James J. Blum, Sr.
Mrs. Constance Blum and
Mr. Stanley L. Blum
Ms. Carol Blymire
Ms. Joslyn L. Boberg
Mr. David S. Boccio
Ms. Natalie J. Boden
Mrs. Willamae Boehs
Mr. Igor Boguslavsky
Mr. Julius Bokodi
Mr. John Bollweg
Mrs. Jamie Bond and
Mr. Victor Bond
Mr. Ronald A. Bongard
Mr. Bernard A. Bonkalski and
Ms. Patricia R. Bonkalski
Mr. Darcy Bonner
Ms. Deborah S. Bookman and
Mr. Stuart Bookman
Mr. David A. Boone
Mrs. Debra B. Boorstein and
Mr. Ronald L. Boorstein
Mr. and Mrs. Daniel J. Boote
Mr. David Booth
Mrs. Kristin Borchers and
Mr. Zachary V. Borchers
Ms. Teri Borkgren
Mr. Alex Borosage
Mr. Stanislav Borysek and
Mrs. Malgorzata Stanislav
Mr. and Mrs. Donald Borzak
Ms. Heather Borzak and
Mr. Peter Borzak
Ms. Nancy Boshes
Mr. Larry D. Bottomley and
Ms. Margaret Bottomley
Ms. Martha M. Boudewyns
Mr. Richard A. Boudreau
Mr. Stephen S. Bowen
Ms. Veronica Boyajian
Ms. Brenda J. Boyd
Ms. Pamela T. Boyd and
Mr. Thomas C. Boyd
Ms. Cheri Boyer
Ms. Helene A. Boyer
Mr. Kenneth Bozorgi and
Mrs. Kenneth Bozorgi
BP Fabric of America Fund
Mr. Lorenzo Bracy
Ms. Elizabeth Bradbury
Gary Bradley and Kim A. Bradley
Mr. Brooke Brady
Ms. Barbara Bragg and
Mr. David T. Bragg
Mr. David Brandhandler and
Mrs. Goldie Brandhandler
Mr. Ted Brandt II and
Ms. Elizabeth Brandt
Mrs. Jean H. Brannigan and
Mr. John M. Brannigan
Mrs. Carolyn J. Brant and
Mr. Dale G. Brant
Mr. James Brault and
Mrs. Margaret Brault
Ms. Frank Brazda
Ms. Carol Brdecka
Caton Bredar
Ms. Linda M. Breger and
Mr. Robert S. Breger
Ms. Lisa G. Bretones
Mr. Norman N. Breyer
Mr. and Mrs. S. Powell Bridges
Mr. Max Brigham
Mr. Phillip Brodie
Ms. Debbie Brody and
Mr. Jeffrey Brody
Mr. Gerry Brown
Ms. Madonna J. Brown
Myra J. Brown
Ms. Rebecca Brownewell
Mr. G. Scott Brownfield and
Mrs. Mary E. Brownfield
Mr. Paul Bruggeman
Ms. Mary L. Bruski and
Mr. Robert B. Bruski
Thomas A. Brusstar
Mr. Wayne Buchanan
Mr. Colman C. Buchbinder and
Mrs. Susan Buchbinder
Mr. and Mrs. Samuel Buchsbaum
Ms. Susan A. Buchta
Ms. Judy Buckman
Ms. Cissy Bunn and
Mr. Willard Bunn
Pauline M. Burelli
Ms. Carol Burgess
Ms. Millicent M. Burgess
Mr. Charles R. Burrus and
Mrs. Mary E. Burrus
Mr. and Mrs. Michael J. Busch
Mr. Christopher Busey
Ms. Amelia Bush and
Mr. Bruce B. Bush
Mr. and Mrs. James Bushnell
Ms. Diane L. Butcher
Mr. Christopher Butler
Mrs. Barbara B. Cabay and
Mr. Michael A. Cabay
Mr. and Mrs. David Cahnman
Mr. Michael Cahr and
Ms. Naoma T. Cahr
Ms. Quyen N. Calixto
Calvey Corp.
Mr. Joseph Cameron
Mrs. Alice J. Campbell and
Mr. Kevin Campbell
Ms. Janice Campbell and
Mr. Mike Campbell
Friends of Cancer Research
Donald Canfield, MBA’77
Mrs. Karen A. Cann
Mrs. Diane F. Cantelo and
Mr. Raymond L. Cantelo
Mr. Robert Capasso and
Mrs. Tami Capasso
Mr. David A. Capp and
Ms. Ruth M. Hennage
Ms. Roberta B. Carden
Cardinal Health Foundation
Carleton College
Carpet Corner Incorporated
Ms. Dana J. Carr and
Mr. Richard A. Carr
Ms. Karen J. Carroll and
Mr. Patrick K. Carroll
Mrs. Mary E. Carroll and
Mr. Michael H. Carroll
Ms. Susan E. Carter
Mr. Clarence Carty
Mr. David C. Cary
Cary’s Mound Farm
Mr. William M. Casey
Ms. Renee A. Catalano and
Mr. Wayne M. Catalano
Ms. Charleyne K. Cawn
Ms. Sherri Cawn
Celebrated Chefs
Mr. and Mrs. Denis Cerezo
Ms. Jean K. Chakour
Ms. Teresa Chan
Ms. Judy Cherchi
Myron M. Cherry and
Ms. Patricia Cherry
Chicago Running Company
Mr. Stephen Chlebowski
Mr. Sheung W. Choi
Mr. Brett D. Christensen and
Mrs. Gale S. Christensen
Ms. Celia Christensen
Mr. Keith J. Christensen and
Mrs. Dawn R. Deines-Christensen
Ms. Beverly J. Christiansen
Mr. and Mrs. Burt Chudacoff
Mr. Edward A. Chupack and
Maria C. Chupack
Ms. Kathleen Ciulla
Ms. Deborah Anne Claflin and
Mr. Eric Carl Marshall
Ms. Denise Clarity
Ms. Faith D. Clark and
Mr. Jason S. Clark
Mr. and Mrs. Charles F. Clarke III
Mr. David B. Clarkson and
Ms. Martha M. Clarkson
Mr. John A. Clement and
Ms. Lauren E. Moltz
Ms. Laura Clements
Ms. Anika Clifton
Mr. Clement Coates
Dr. Ian D. Cohen and
Mrs. Sandra M. Cohen
Ms. Stephanie N. Cohen
Mrs. Elaine Stone Colburn
Ms. Joan Colby
Mr. Arthur Coleman
Dr. Geraldine Balut Coleman
Collectors Club
Ms. Linda Collins
Mr. Mark Collins
Ms. Carol E. Collopy
Mrs. Lillian Y. Colwell and
Mr. Robert W. Colwell
Community Shares of Minnesota
Ms. Joan Compernolle
Ms. Crissy T. Condes and
Mr. John M. Condes
Mr. James Condes
Mr. Harold Conick
Mr. Gregory G. Connell and
Mrs. Sally H. Connell
Mr. John W. Connelly and
Mrs. Kathleen Connelly
Ms. Megan Connolly
Mrs. Joanne M. Connors and
Mr. Shawn M. Connors
Dr. Henry Conroe and
Harriet Conroe
Ms. Elaine Conroy
Ms. Ellen V. Cook
Ms. Deborah H. Cook and
Mr. Thomas E. Cook
Mr. John Cookinham
Ms. Adrienne Cool and
Ms. Anne E. Simon
Mr. Jesse Cool
Mr. Neil R. Cooper and
Mrs. Sheri Cooper
Mrs. Rachel Cooper and
Mr. Ronald Cooper
Mr. Bradley Cordes and
Mrs. Karen Cordes
Mrs. Andrea Cordova and
Mr. Jeffrey Michael Cordova
Mr. Thomas M. Corridon
Ms. Lisa Corso

Dr. Timothy Michael Cotter
Mr. Daniel E. Coughlin and
Ms. Jo Anne Coughlin
Mr. Darrell K. Cousert
Mr. David Cousert
Cousert’s Consulting LLC
Mr. George R. Couture and
Mrs. Susan M. Couture
Mr. and Mrs. Arnold D. Cowen
Ms. Kate Cox
Ms. Kay Coyne
Mr. Cary C. Crawford and
Ms. Mary E. Crawford
Ms. Jodi Crawford and
Mr. William Crawford
Ms. Monica Moira Creighton and
Mr. Darrell J. Graham
Mr. Christopher
Crisman-McQuarrie
Ms. Patricia A. Cronin
Mr. and Mrs. J. Michael Crouch
Mr. Brian Crouch and
Ms. Katherine Crouch
Ms. Morgan Crouch
Mr. Edward A. Culbertson
Mr. Andrew Cummings
Ms. Barbara C. Cunningham
Barbara Flynn Currie, LAB’58,
AB’68, AM’73
Mr. John Curtis, Jr.
Mr. Robert Cutler
Ms. Sandra L. Cutler
Mr. Joseph W. Cwynar and
Mrs. Veronica L. Cwynar
Ms. Denise Czuprynski
D.B. Ureel and Associates
Dr. and Mrs. Abraham H.
Dachman
Ms. Doris Dallow
Mrs. Nancy L. D’Andrea and
Mr. Patrick M. D’Andrea
Mr. Clarence M. Darrow
Ms. Babette R. Daskin and
Mr. Mark S. Daskin
Mr. Fred Daubenspeck
Mr. Ryan Davenport
Mr. and Mrs. Robert M. David
Ms. Rebecca Davidson
Mr. Dick Davis and
Mrs. Joan Z. Davis
Mr. Andrew J. Davis and
Mrs. Michele M. Davis
Ms. Eva Davison
Ms. Dale Davison and
Mr. William Davison
Ms. Linda Dawe
Deane Day
Mr. Craig Dean and
Mrs. Kelly M. Dean
Mr. Santolo M. Deblasio
Mr. Hybo L. De Blecourt
Mr. Bert Dech
Ms. Gabriele Dech and
Mr. Dennis DiChiaro
Mr. Michael F. DeFranco
Mr. Philip De Giulio
Mr. Clarence DeGroot, Jr.
Ms. Joan E. Dehnert
Mrs. Eulaine A. Deist and
Mr. Robert R. Deist
Mr. and Mrs. Robert O. Delaney, Jr.
Mr. Daniel R. Den Boer and
Ms. Nancy E. Den Boer
Mr. William Denis
Jacquelyne Denuyl
Ms. Cheryl A. Desmet
Mr. Ronald DeTella
Ms. Ellen Dettling
Mrs. Patricia A. Deveney and
Mr. Roy T. Deveney
Ms. Katrina M. Devinner
DeWitt Area Swim Team
Mr. Douglass Diak
Mr. Brian Dick
Ms. Dorothy L. Dickens
Ms. Leslie Dickens
Mr. and Mrs. Nathaniel Dickson
Ms. Barbara DiCola
Mr. Patrick J. Diercks
Mr. James P. DiGiacomo
Ms. Jamie Doering
Mr. Edward Doherty
Mr. Ronald Z. Domsky
Mr. Daniel James Donoghue and
Ms. Margaret A. Donoghue
Mrs. Nancy S. Donovan
Dr. and Mrs. Heratch O.
Doumanian
Mr. Demetrios Dourdourekas
Mr. J. L. Driskell and
Mrs. Jane Driskell
Mrs. Kim N. Driskell and
Mr. Tim L. Driskell
Mrs. Anne Drook and
Mr. Ryan Drook
Mrs. Kylie Drummond and
Mr. Nathaniel Drummond
Ms. Helene Dubow
Mr. George E. Duchossois
Ms. Rosemary Dudlack
Ms. Karen Duffy and
Mr. Harvey Gould
Mr. Matthew Dvorak
Mr. Randall Dvorak
Mr. Michael J. Dwyer
Dr. Werner R. Dziadzka
E.C. Babilla, Inc.
Dr. Marjean Evelyn Eastmond
Mr. and Mrs. Louis A. Ebert
Mrs. Barbara M. Ebling and
Mr. Byard T. Ebling
Mr. James Eder
Ms. Christine Edwards
Dr. Elena Efimova
Mrs. Gina J. Ehlman and
Mr. Todd J. Ehlman
Mr. Arthur R. Ehrlich and
Mrs. Vanessa M. Ehrlich
Ms. Lynn Eikenbary
Mr. and Mrs. Patrick Eilers
Ms. Rita A. Eilers
Mrs. Michelle E. Einck and
Mr. Ryan J. Einck
Ms. Jean M. Einstein
Ms. Adrienne Eisenmann
Mr. Jeff Eizenberg
Mr. Dwight A. Ekenberg
Ms. Jenna Elder
Ms. Ronda Elesh
Ms. Marcia Elkin
Ms. Abigail Frankel Elkins and
Mr. Gary Elkins
Dr. Leonard D. Elkun
Ms. Janis R.E. Elliott
Ms. Mary Jo Ellis
Ms. Martha Ellsworth
Mr. Kevin G. Elmore and
Mrs. Margo M. Elmore
Steven M. Elrod and
Donna R. Elrod
Mr. William J. Embry
Ms. Laura England
Ms. Judith M. Epstein
Mr. Leslie F. Epstein and
Mrs. Linda S. Epstein
Mr. and Mrs. Daniel K. Ericson
Ms. J.K. “Jan” Erikson-Vroman
Mr. William J. Essig
John Estey, MBA’76
Mr. Allan Etzbach
Ms. Rebecca Etzler
Ms. Susan M. Evans
Mr. Robert P. Evans and
Mrs. Vicky L. Evans
Evergreen Park Community
HS Dist 231
Mr. James Evitts
Mr. John R. Eychaner
Mr. Dale Eyer and Mrs. Terri Eyer
F. L. Corp-One
Ms. Vanessa D. Fabbre
Mrs. Beverly A. Falkenberg and
Mr. Jack D. Falkenberg
Mr. Donald P. Farber and
Ms. Joanne D. Farber
Mr. Thomas Farris
Ms. Kolbrun K. Fass
Ms. Elizabeth T. Faulkner
Dr. and Mrs. Peter J. Feczko
Dr. Eugene Andrew Choi and
Ms. Savitri Erika Fedson
Ms. Aubrey Feeney
Mr. Frank W. Feiler and
Mrs. Ruth N. Feiler
Dr. Kate Feinstein
Ms. Sheree Feldman
Ms. Dawn E. Fensterbusch
Ms. Elizabeth A. Feren and
Mr. Sean P. Feren
Ms. Laura Ferkel
Ms. Nancy Fertig
FEV, Inc.
Mr. Nathan Finch
Mr. Neil Finerty
Ms. Deborah L. Finger
Mr. Yefim Finkler
Mr. John Finnell and
Mrs. Patricia Finnell
Ms. Connie K. Fiorito
Mrs. Joanne Fischer and
Mr. Peter D. Fischer
Mr. David Fishbaum
Mrs. Linda S. Fisher and
Mr. Rodney W. Fisher
Gene Fisher, PhB’45, MBA’48
Mr. Scott M. Fisher and
Mrs. Lynne S. Manna-Fisher
Dr. and Mrs. Frank W. Fitch
Ms. Mary G. Fitzpatrick
Ms. Eileen Flaherty
Michael J. Flaherty, MD
Mrs. Janice E. Flahie and
Mr. Thomas J. Flahie
Ms. Donna K. Fletcher
Ms. Kathie Florsheim
Mr. Phillip A. Floyd and
Mrs. S. Floyd
Mr. Michael P. Foradas and
Mrs. Valerie R. Foradas
Ms. Francine R. Fossler
Ms. Ann Foster
Ms. Laura A. Foster
Mrs. Mary Foster and
Mr. Richard Foster
Mr. Randolph H. Foster
Ms. Annie Laurie Foust
Miss Lisa G. Fox
Dr. and Mrs. Harry A. Fozzard
Mrs. Tamara Fracasso and
Mr. Joseph J. Fracasso, Jr.
Mr. and Mrs. Fielden Fraley
Ms. Mary Frances
Mr. Ben Frank and
Ms. Wendy Maislen Frank
Mr. Gunther Frank and
Mrs. Inge J. Frank
Ms. Christine C. Franklin
Ms. Deborah K. Freeman and
Mr. W. Randall Freeman
Ms. Margareta N. Freeman and
Mr. Leonard Samuel Levin
Ms. Peggy L. Freeman
Mrs. Helen R. Friedli and
Mr. Kipp Friedli
Mr. Albert M. Friedman and
Ms. Suzanne Friedman
Mr. Franklin L. Friedman
Mr. Mark Friedman
Mr. Michael Davidson Friedman
and Ms. Margaret Ann Berger
Ms. Lynn L. Friend and
Mr. Marc H. Friend
Mr. David Fritzsche and
Mrs. Jennifer M. Fritzsche
Mrs. Carol A. Froelich and
Mr. Eugene C. Froelich
Mr. Jerold A. Frost and
Mrs. Jerold Frost
Mr. Jack R. Frymire and
Mrs. Kelle A. Frymire
Mr. Wolf D. Fuhrig
Ms. Katie A. Fulara
Ms. Sharon Fulla
Mr. David P. Fuoss
Ms. Kathleen A. Fuoss
Mr. and Mrs. Donald M. Fyfe
Dr. and Mrs. Damien A. Gabis
Ms. Stacy E. Gagas
Mr. Fred Richard Gagliano and
Ms. Linda R. Gagliano
Sahara Enterprises, Inc.
Mr. Mark Gaines and
Mrs. Nina Gaines
Mr. John Galambos
Mr. and Mrs. John Galassini
Ms. Leah Gale
Ms. Gwen F. Gallagher
Ms. Peggy G. Gallagher
Mr. Jon Galli
Ms. Marcia Galloway
Mr. and Mrs. Michael P. Galvin
Dr. Jia-Hong Gao
Mr. Michael J. Garcia
Ms. Susan M. Garstki
Mrs. Patricia C. Garvy
Mr. John Gaski
Mrs. Carole J. Gatch
Ms. Rosemarie Gatehouse
Ms. Catherine Gatewood
Mrs. Cynthia L. Gathman and
Mr. M. R. Gathman
Mr. Joel Stanley Geier and
Candace Cohn
Mr. Mark Geissler and
Mrs. Ruth Geissler
Pamela Lynn Gellen, Esq.
Dr. Harry K. Genant and
Dr. Gail W. Genant
Mr. Nikolay Georgiev
2011–2012 donors
57

Mr. Donald Gerdes and
Mrs. Ramona Gerdes
Mrs. Amy L. Gerstein and
Dr. Craig H. Gerstein
Mr. David Gertz
Mr. Julian A. Gestrin and
Ms. Marilyn L. Grey
Dr. Gary G. Ghahremani
Ms. Gargi Ghosh
Mr. John Giampoli
Mr. and Mrs. Paul L. Giancarlo
Mr. Gary Gibbins and
Mrs. Linda L. Gibbins
Ms. Marjorie C. Gibbins
Mr. Brian Gift
Mr. Richard Benjamin Gift
Dr. Charles C. Giger and
Dr. Maryellen L. Giger
Ms. Amy Lynn Gill
Mr. and Mrs. Laurence M. Gill
Mr. R. Scott Gill
Mr. James E. Gillespie and
Ms. Josephine M. Gillespie
Ms. Mary R. Gilmore
Ms. Nell Gingerich
Mr. Christopher E. Girgenti and
Ms. Maryellen Girgenti
Ms. Karen A. Gitles
Ms. Claire K. Gladden
Mr. Brad Glass and
Ms. Martha Glass
Mr. Bruce Glass and
Ms. Randi F. Glass
Mr. Joseph K. Glatterman and
Mrs. Marian B. Glatterman
Ms. Nancy Glazer
Ms. Lisa Glennon
Marion Glicksberg
Ms. Mary Godich
Dr. Bruce Goethe
Mrs. Jodie L. Goetz and
Mr. Paul J. Goetz
Ms. Laura Gold
Ms. Beth Goldberg
Mr. Daniel Lawrence Goldberg
and Ms. Betsy Nathan
Ms. Margaret Goldberg and
Mr. Michael A. Goldberg
Mrs. Emily Golden and
Mr. John Golden
Ms. Robyn L. Golden
Mr. Phillip Golding
Mr. and Mrs. Dennis K. Goldman
Ms. Marcy Goldman
Mrs. Dolores Goldman and
Dr. Stewart Goldman
Mrs. Ellen Z. Goldsher and
Mr. Scott Goldsher
Ms. Ilene Goldstein
Ms. Gerry Gomberg
Mrs. Debbie Goodman and
Mr. Wayne M. Goodman
Mr. David E. Gordon and
Ms. Stacy J.B. Gordon
Ms. Kristina Gordon
Mr. Paul Gordon
Ms. Annalisa Graham
Mr. Douglas Graham
Ms. Lisa M. Graham
Gramm Family Foundation
Mr. Robert N. Grannick and
Mrs. Carol C. Grannick
Mr. Jeffrey N. Grant and
Ms. Joanne Grant
Mr. Kevin Grant and
Mrs. Teresa A. Grant
Mr. Kevin Gratkowski
Mr. John E. Graves and
Mrs. Lynne S. Graves
The Avrum Gray Family Fund
Mr. Melvin Gray
Ms. Karen Gray-Keeler and
Mr. Thomas Keeler
The Greater Kansas City
Community Foundation
Mr. Alan Green and
Mrs. Debbi Green
Geri Greenberg
Mr. Allen Greenberger
Mrs. Jo Ann Greenblatt and
Mr. Richard L. Greenblatt
Dr. Geoffrey L. Greene and
Dr. Marianne E. Greene
Mr. John Kaul Greene and
Mrs. Jean McBride-Greene
Mr. and Mrs. Ronald Greenspon
Dr. Robert J. Gresick
Ms. Amy Greywitt
Mr. James L. Grider and
Ms. Theresa D. Grider
Mrs. Caryl K. Griffith and
Mr. Donald F. Griffith
Ms. Sarah Griffith
Daniel R. Grifka, DDS and
Rene S. Grifka, MS
Ms. Lois A. Grissom
Ms. Julie Groos
Ms. Joan Grossbart
Mr. James Grskovich
Ms. Ann M. Grupczynski and
Mr. David A. Grupczynski
Mr. Leroy Gualandri
Mrs. Hilde Guenther and
Mr. Oskar Guenther
Ms. Sharon L. Gums
Ms. Sharyn Lee Gunderson
Ms. Bimla Gupta and
Mr. Ram C. Gupta
Ms. Dawn Gupta
Ms. Jacqueline Gupta
Ms. Manju Gupta
Dr. Sonal Gupta
Mr. Kartik Gururajan
Mr. Jeremy Guterl
Ms. Amy Guth
Ms. Jamie M. Hagedorn
Ms. Teri L. Hagedorn
Ms. Joyce C. Hahn
Mr. David Hall
Ms. Monies Q. Halloran
Mr. Michael Ham
Ms. Annie Hambleton
Mr. James L. Hamilton
Mr. Ira M. Hamilton and
Mrs. Marilyn Hamilton
Ms. Sharon R. Hamilton
Mr. Charles P. Hammersmith, Jr.
Mrs. Jayne Hanauer and
Dr. Stephen Hanauer
Joel L. Handelman, JD’65
Ms. Femida Handy
Ms. Grace L. Hanny and
Mr. James P. Hanny
Mr. John Hansen and
Mrs. Julianne Hansen
Ms. Kimberly K. Hanson and
Mr. Mark D. Hanson
Ms. Peggy Rose Hanson
Mr. Steven Hanson
Mr. James Hantak
Mr. Adam Haravon
Mr. Christopher Harbert and
Mrs. Laurie Harbert
Mr. David A. Harbin
Mrs. Georgia D. Harbin
Mr. William Harden
Mr. Dale Hardesty and
Mrs. Shirley Hardesty
Ms. Lynda Harland
Harold W. Conick &
Associates, Ltd.
Ms. Dolores W. Harp
Ms. Marilyn J. Harrington
Ms. Cheryl Harris
Mrs. Sheldon Harris
Ms. Margaux Harrold
Mr. Harvey E. Hartman and
Ms. Patricia M. Hartman
Ms. Kirstin Hartman
Ms. Brenda Hartmann
Ms. Margaret Hartney
Ms. Janet Hartwig
Ms. Jeanne A. Hartzell
Ms. Judith Hasak and
Mr. Nehemiah Hasak
Mr. Albert Hasson and
Mrs. Marlee Hasson
Mrs. Tara A. Hausmann and
Mr. John E. Hausmann II
Hiroshi Hayakawa
Ms. Geraldine Hays
Health Services
Ms. Mary M. Healy
Mr. Mark S. Heaney and
Ms. Susan J. Heaney
Ms. Nyla A. Heerema
Mr. and Mrs. Charles Heery
Ms. Eve Heffer
Jeanne Heffernan, AM’94, JD’02
JoAnne Heffernan
Steve and Janice Hefter
Family Foundation
Mr. and Mrs. Steven J. Hefter
Ms. Jane Heilstedt and
Mr. John E. Heilstedt
Ms. Dorothy M. Heinen
Mr. Jeff Heisler
Ms. Nadege Helias
Mr. Jason Marc Heltzer and
Ms. Wendy Heltzer
Mr. John Henke
Dr. Gregory Alan Henkle
Mr. Daniel K. Henry and
Mrs. Jessica B. Henry
Mr. David Hensel
Mr. Joel A. Herman and
Mrs. Jennifer A. Herman
Mrs. Patsy M. Herman and
Mr. Robert L. Herman
Mr. Mark J. Borman and
Ms. Karen B. Hermelin
Mr. and Mrs. Roberto Hernandez
Robert Hernquist and
Dorothy Hernquist
Mr. Joel M. Hershberger and
Ms. Lois M. Hershberger
Ms. Mindy Herskovitz
Michael A. Herst, CFA and
Ms. Wendy Herst
Mrs. Patricia Hickey and
Mr. William R. Hickey
Mrs. Barbara P. Hicks and
Mr. Stephen B. Hicks
Mr. Lawrence E. Hicks and
Mrs. Mary Lou Hicks
Mrs. Heidi Higgins and
Mr. Peter Higgins
Mr. and Mrs. Robert Hinerfeld
Mr. James J. Hipp
Mr. Andrew Hirsh
Mr. Douglas A. Hirsh
Mr. David Ho
Mr. Andrew S. Hochberg and
Ms. Laurie Hochberg
Mr. Joel Hoffman
Ms. Mary Hoffman
Ms. Julie A. Hokin
Mr. and Mrs. William J. Hokin
Ms. Ashley N. Holmes
Mr. Harold Rodney Holmes
Ms. Jessica Holzman
Honeywell International
Foundation, Inc.
Mr. and Mrs. William L. Hood
Rachel Kohler and
Mark Hoplamazian
Ms. Corlene W. Horan and
Mr. Peter V. Horan
Mrs. Ariel N. Horowitz and
Mr. Jesse B. Horowitz
Mr. Allen B. Horowitz and
Mrs. Claire Horowitz
Mr. David J. Horowitz and
Mrs. Janet Horowitz
Mr. and Mrs. William E. Horowitz
Mrs. Walter G. Horschke
Ms. Karen Horwitz
Hospira Employee
Giving Campaign
Friends of the Hospital
Ms. Susan E. Hovis
Mr. Homer C. Howell and
Mrs. Nettie A. Howell
Mr. Daniel C. Howey and
Mrs. Lorraine K. Howey
Mr. John Huff
Ms. Susan Huiner
Mr. Michael J. Humbach and
Mrs. Paula C. Humbach
Ms. Sarah M. Humpal
Mrs. Cathy D. Hunt and
Mr. Ronald L. Hunt
Ms. Susan Hunt
Mrs. Brenda B. Hurst and
Mr. Charles J. Hurst
Mr. Michael Huspek
Lynette M. Iannantuoni and
John E. Iannantuoni, SB’63
Ms. Susanne Immell
In Depth Marketing
Mr. Larry B. Ingvalson and
Ms. Lynn S. Ingvalson
Ms. Anna Clara Ionta
Mr. Davia K. Irion and
Mrs. Patricia L. Irion
Ms. Alyce M. Itta
Mrs. Arlen Ivanauskas and
Mr. Thaddeus Ivanauskas
J.H. Bollweg Building Partnership
Mrs. Alice M. Jackson and
Mr. Jasper Jackson
Mrs. Faye R. Jacobs and
Mr. Joshua J. Jacobs
Ms. Sarah Bristow Jacobs and
Mr. Michael J. Jacobs
Mr. Thomas A. Jacobs
Gary A. Jacobsen, MD
Ms. Fern Jacobson and
Mr. Irwin Jacobson
Thomas A. Jaekel and
Mary K. Jaekel
The Jaffee Foundation
James & Williams Jewelers

Mr. Brian J. Jansen and
Mrs. Kathryn B. Jansen
Mr. Peter Jarrell
Sidney F. Jarrow
Mr. James Jaske
Ms. Geraldine Jenkins
Ms. Janie Jenkins
Mr. and Mrs. Kirk Jenkins
Ms. Karen Jensen
Dr. Randall J. Jester
Jewish Federation of
Metropolitan Chicago
Johnson & Johnson
Family of Companies
Ms. Anne Marie Johnson
Ms. Charlotte Johnson
Mr. Allen L. Johnson and
Mrs. Debra D. Johnson
Ms. J. Kim Johnson and
Mr. Randall P. Johnson
Mr. and Mrs. Bruce Johnson
Mr. Kenneth A. Johnson and
Mrs. Janet F. Salmon
Mr. Kenneth J. Johnson
Ms. Lisa J. Johnson
Ms. Rachel Johnson
Mrs. Mary G. Johnson and
Mr. Scott F. Johnson
Mr. George Johnston
Mrs. Candance J. Johnston and
Mr. Harold J. Johnston
Vivian G. Johnston, Jr., Esq
Mr. David C. Jones
Mr. David P. Jones
Ms. Natha Jones
Ms. Starla Jones
Mr. Arthur D. Jordan
Ms. Jennifer P. Josefchak
JP Morgan Chase Foundation
Just Give
Mr. and Mrs. Clark Justice
Laurie S. Kabb, LCSW and
Mr. Zachary Kabb
Mr. Vernon Kagan
Mr. David L. Kahn and
Mrs. Susan Kahn
Ms. Elaine Kahn
Mrs. James Kahnweiler
Mr. George M. Kaiser
Mr. Ronald A. Kalemba
Mr. Donald J. Kallin
Mr. Gregory Kalman and
Ms. Marissa Hernandez Kalman
Ms. Joanne Kalnitz and
Mr. Marshall Sorkin
Ms. Katie Kanaris
Mr. Peter E. Kanaris
Dr. Kannan Kandallu and
Mrs. Ramaprabha Kandallu
Ms. Elizabeth T. Kane and
Mr. Gregory Kane
Mr. Solomon Kane
Mr. Jeffrey Kania and
Mrs. Kelly Kania
Mr. Benjamin F. Kanter
Ms. Yvette Kanter
Mr. Rupesh Kapadia
Ms. Gerry Kaplan
Ms. Lori Kaplan
Ms. Julie Karagianis
Dr. Gregory S. Karczmar and
Ms. Kelly A. Karczmar
Mr. Lawrence Karikari
Dr. George Karkazis and
Mrs. Myrsini Karkazis
Ms. Judith M. Katz
Ms. Anita B. Katz and
Mr. Michael D. Katz
Mr. Gregory Katzman
Mr. and Mrs. Robert W. Kaufman
Ms. Elizabeth Helene Kawior
Mr. Daniel Kearney
Ms. Linda E. Kelley
Ms. Lynnette Kelly
Mr. Michael James Kelly
Ms. Patricia A. Kemper and
Mr. Robert J. Kemper
Ms. Phyllis Kendall
Kenilworth Cleaners
Ms. Micki Kennedy
Ms. Elizabeth M. Kernahan
Ms. Susan Kessler
Mr. and Mrs. Joseph D.
Kestnbaum
Mr. Ray J. Kevorkian
K-Five Construction Corporation
Mrs. Farah Khosravani
Mr. John J. Kiernan and
Mrs. Sharon M. Kiernan
Ms. Margaret S. Kiernan
Kies Consulting, LLC
Mr. Bruce C. Kietzman and
Mrs. Lori L. Kietzman
Ms. Stacey Leigh Kigar
Ms. Catherine King
Mr. William V. Kirchgessner
Mr. Philip James Kirk, Jr. and
Ms. Judy Kirk
Mr. Gary Kirshenbaum and
Joanne Kirshenbaum
Ms. Ana Akemi Kitazono
Ms. Amy Klein
Ms. Kristen L. Klein
Mrs. Dayna Kleinman
Ms. Ardie J. Klement
Ms. Katherine Klement
Ms. Laura Klement
Mr. Timothy Anthony Klewicki
and Mrs. Carol Klewicki
Mr. Clifford Klotz
Mr. James M. Knape and
Mrs. Laurieanne M. Knape
Karl Knauz Motors
Mrs. Cheron M. Kneedy and
Mr. Mark J. Kneedy
Lauren C. Knoche
Mr. Gene J. Kocian and
Mrs. Peggy D. Kocian
Mr. Ken Koehler
Ms. Katharine A. Koehler and
Mr. Richard A. Koehler
Ms. Christine C. Kohnke
Ms. Catherine A. Kolet
Mr. Rajasekhar Kolla
Mr. and Mrs. Bernard Kompare
Ms. Ruth J. Kooi
Ms. Karen Kopin
Mr. Steven N. Koppes
Ms. Joan T. Kornblatt
Ms. Andrea Koti
Ms. Jacqueline Kott and
Mr. David S. Wolle
Ms. Carol L. Kozola
Kraft Foods, Inc.
Mrs. Jennifer L. Kraft and
Mr. Kyle R. Kraft
Mr. Steven G. Blim and
Ms. Kelly A. Kramer
Mr. and Mrs. Ludwig Krammer
Mr. Richard C. Kraneis and
Mrs. Sina Kraneis
Ms. Mary Ann Krebs
Mrs. Hope Krimsin and
Mr. Mickey Krimsin
Mr. Richard E. Krinn
Ms. Leslie Kroeger
Mr. Morton A. Krongold
Mr. Devery J. Krupchak and
Mrs. Elizabeth W. Krupchak
Mr. Russell Kruse
Mr. Mark J. Kubajak
Mr. and Mrs. John A. Kuhlman, Jr.
Mr. Dwayne Kuipers
Mr. Robert Stephen Kukulka and
Mrs. Sofia Kukulka
Ms. Ragini Kumari
Mr. Alexander Kumskis and
Ms. Nancy E. Kumskis
Mr. Marshall Kuphan
Mrs. Cheryl Kurtenbach and
Mr. Donald Kurtenbach
Mr. R. M. Kurzydlo
Mr. Eliot Wing-Chung Kwok
Mr. Edward K. Laatsch and
Mrs. Betty Laatsch
Mr. Bryan R. Lagree and
Mrs. Cynthia L. Lagree
Mr. Brian Lahann
Ms. Rose Laketa
Mr. George S. Lalich and
Mrs. Cathy Z. Lalich
Mr. and Mrs. Alex Lallanilla
Mr. John Lamantia
Ms. Bridget L. Lamont
Mr. Charles R. Lamphere and
Mrs. Sarah K. Lamphere
Ms. Maria Lampros
Mr. David Landsittel, MBA’63
Ms. Judith A. Lang
Mr. Peter John Langas and
Ms. Jacqualine Langas
Mr. Robert D. Lange
Mrs. Cynthia M. Langendorf and
Mr. Robert A. Langendorf
Mr. George F. Lannon and
Mrs. Marie Lannon
Mr. Alvin Lapper
Ms. Heather La Riviere and
Dr. Patrick J. La Riviere
Ms. Deborah Larsen
Ms. Linda Larsen
Mr. Donald M. Larson
Mrs. Judie A. Lasser and
Mr. Robert P. Lasser
Ms. Yvonne T. Lasser
Mr. Bernard Latham
Mr. Robert Lauer
Mr. Jeffrey Laurinas
Mr. Warren Lavey and
Dr. Holly Rosencranz
Ms. Sarah Lawlor
Mr. John Lawrence and
Mrs. Kelly Lawrence
Mr. Timothy J. Lawrence
Ms. Antoinette Lazzara
Mrs. Carla Lazzara and
Mr. Joseph E. Lazzara
Mr. George Lebamoff
Mrs. Ellen S. Lee and
Mr. Steven M. Lee
Mr. Roy Lee
Ms. Lori R. Lefstein
Ms. Mary Jo Lendl
Lenticlear Lenticular Lens, Inc.
(DBA)
Mindy Leonard
Ms. Autumn Leslie
Ms. Agnieszka Lesniak and
Mr. Zenon Lesniak
Mrs. Aliza Lesser and
Mr. Michael Lesser
Mr. Michael L. Lester
Mrs. Marci Levenfeld and
Mr. Scott Levenfeld
Mr. Jonathon Levin and
Mrs. Rachel B. Levin
Levine & Glassman, LLC
Mr. Robert A. Levinson and
Ms. Theresa L. Levinson
Mrs. Betsy A. Levy and
Mr. Robert L. Levy
Mrs. Anne Marie Levy and
Mr. Paul M. Levy
Mrs. Janet G. Lewis
Helene R. Lewison and
Mr. Murray J. Lewison
Mr. James Leyden
Mr. Albert C. Li
Mr. Michael Lichtenstein
Mr. James Lieberman
Mr. and Mrs. David L. Liebman III
Mr. Gerald A. Lienhart and
Ms. Linda S. Lienhart
Ms. Shin Yi Lim
Ms. Susan Lindholn
Ms. Gail Lingle
Ms. Sandra Linn
Ms. Francine Lipsman and
Mr. Michael L. Tansey
Mrs. Olga I. Lishanskaya and
Mr. Mikhail Lishanskiy
Ms. Lucy T. Liu
Dr. Zhendong Liu and
Dr. Zhen Feng Lu
Ms. Claude Lo Piccolo
Mrs. Mary W. Locher
Mrs. Courtney C. Loeb and
Mr. Edward S. Loeb
Mr. and Mrs. John H. Loecke
Mr. Ernest Lohmar
Ms. Kelly Lombardo and
Mr. Scott Lombardo
Mr. Alan C. London and
Ms. Barbara J. London
Judith Louis and Maynard Louis,
AB’47, MBA’49
Mr. Alexander Lourie and
Ms. Mary Beth Lourie
Ms. Melissa Love
Mr. Douglas Jon Lubelchek and
Mrs. Lisa Lubelchek
Mr. Darrell J. Lucas and
Ms. Linda S. Lucas
Ms. Arlene Lulich and
Mr. Matthew N. Lulich
Mr. James H. Lusk and
Mrs. Janet Lusk
Ms. Randi Lustig
Mrs. Catherine M. Lutz and
Mr. Geoffrey Lutz
Ms. Elaine N. Lydon and
Mr. Thomas A. Lydon
Ms. Margaret A. Lyman
Mr. James L. Lynch
Mr. and Mrs. Michael
Courtney Lynch
Ms. Nancy L. Lyon
The John D. and Catherine T.
MacArthur Foundation
Mr. Douglas B. Maccallum and
Ms. Kristin J. Ortloff
Mr. Kevin MacKey and
Mrs. Maria MacKey
Ms. Katherine Liu and
Dr. Heber MacMahon
2011–2012 donors
59

Mr. Craig H. Madding and
Mrs. Patsy J. Madding
Ms. Deborah L. Madlener
Ms. Constance F. Magnuson
Dr. John J. Magon
Ms. Katherine M. Magon
Mr. Suresh Mahadevan
Ms. Susan H. Maher
Mr J. David Maher and
Mrs. Tracy Maher
Mr. Peter Mahoney
Ms. Ann Maine
Ms. Sheryl Malbon
Mr. Howard Malecki and
Mrs. Jane Malecki
Mr. James Maletich
Dr. Jay C. Mall
Ms. Elizabeth A. Mallon
Ms. Megan Malone
Ms. Karen M. Manczko and
Mr. Michael W. Manczko
Ms. Beth Mand and
Mr. Michael Mand
Ms. Kathleen Manilla
Mr. and Mrs. Brian Manion
Ms. Catherine Mann
Ms. Pat Manning
Mr. and Mrs. Stephen P. Manus
Mr. Edward Marcin
Michael Marcus and
Lauren Marcus
Mr. and Mrs. Stephen A. Marcus
Mr. Glen M. Marder and
Mrs. Majorie Marder
Mr. Charles F. Marino and
Mrs. Jean G. Marino
Ms. Karen Markin
Mr. Jonathan Markowitz and
Mrs. Ruth F. Wenger
Ms. Tammy Marks
Ms. Leta I. Marlett
Ms. Amy Marriott
Ms. Kelly Marshall
Mrs. Kimberly J. Marshall and
Mr. Leo S. Marshall
Ms. Carole A. Martin and
Mr. Ronald D. Martin
Mr. David L. Martin
Ms. Elizabeth J. Martin
Ms. Georgann M. Martinkus
Ms. Ann K. Martinmaki
Ms. Ann L. Martinson
Ms. Emily Mason
Mrs. Cacilia F. Masover and
Mr. Lee R. Masover
Mr. and Mrs. Salvatore Massanisso
Maternity BVM School
Ms. Janet S. Mathews
Mr. Robert P. Mathias
Mr. Theodore Mathias
Mr. John W. Matkey
Ms. Beverly A. Matre
Mr. Gregory Mattingly and
Mrs. Nancy Mattingly
Mrs. Joanne G. Matuszewski and
Mr. Karl A. Matuszewski
Ms. Judith Matz, LCSW
Mr. Joseph Matz and
Ms. Lorraine Matz
Dr. Jacqueline M. Griesdorn and
Mr. Kevin D. Matzke
Maurice Fund
Ms. Ellani Maurides
Mr. Michael Maxey
Mr. and Mrs. Isaac Mayefsky
Mr. Jesse L. Mayer
Mrs. Anne Mayerfeld and
Mr. Russell K. Mayerfeld
Mrs. Julie L. Mayfield and
Mr. Thomas M. Mayfield
Ms. Kelly E. Maynard
Mr. Michael Mazurczak II
Ms. Ellen Mazza
Ms. Linda J. McBride
Ms. Amy McCarthy
Mrs. Kathleen McCarthy and
Mr. Michael McCarthy
Ms. Joan Q. McClellan
Mrs. Donna McClung and
Mr. Edward McClung
Ms. Pamela A. McCord
Ms. Mary Beth McCrory
Mrs. Margaret Anne McCue
Ms. Anne McDonagh
Ms. Paula S. McDonald
Mr. Robert U. McDowell
Ms. Robin Josephs and
Mr. Patrick McGarvey
Mr. Michael B. McGill and
Mrs. Susan McGill
Ms. Barbara K. McGonagill
Ms. Rose McGowan
Mr. J. Bates McIndoe and
Ms. Judith P. McIndoe
Mr. Vaughn Anthony McKinney
Ms. Patricia A. McKown and
Mr. Timothy McKown
Mrs. Betty McLean and
Mr. William H. McLean
Ms. Lindy McLean
Ms. Cynthia A. McNally
Ms. Marianne E. McNulty
Mrs. Christine M. McNulty and
Mr. Patrick J. McNulty
Mr. Don McQuilkin
Ms. Patricia A. McTague
Mecor
Mrs. Janice A. Meier and
Mr. Michael M. Meier
Mrs. Jodi B. Meister and
Mr. Kenneth A. Meister
Mr. and Mrs. Nicholas J. Melas
Ms. Mary C. Mellon
Ms. Francisco Menchaca
Ms. Lorraine Mendoza
Ms. Rochelle Meng
Ms. Samantha Menne
Mr. Joseph Meny
Mr. Rolando Calderon Mercado
Merix Pharmaceutical Corp.
Dr. Charles E. Metz*
Mr. Douglas L. Meyer
Ms. Jean F. Meyer
Mr. Jerome H. Meyer and
Mrs. Linda Meyer
Mr. Jason Meyers and
Ms. Julie Meyers
Dr. Edward Andrew Michals and
Ms. Sheryl P. Bury-Michals
Ms. Anne S. Michel and
Mr. Mark A. Michel
Mr. Ravi S. Mikkelsen
Mr. Steven Milenkov
Mr. Michael L. Millenson and
Mrs. Susan Millenson
Ms. Barbara J. Miller and
Mr. Dale R. Miller
Mr. Curtis C. Miller and
Ms. Joan K. Miller
Mrs. Cynthia L. Miller and
Mr. Robert D. Miller
Mr. G. Richard Miller
Mr. Alan B. Miller and
Mrs. Judith L. Miller
Mrs. Julie E. Miller
Mr. Barry A. Miller and
Mrs. Laura Miller
Ms. Mary H. Miller
Mr. James R. Miller and
Ms. Penny L. Miller
Mr. Todd Miller
Mr. Mike Erskine and
Ms. Jackie L. Miller-Erskine
Mr. Andrew J. Mills and
Ms. Nancy Mills
Ms. Tina Mills
Ms. Julie B. Min
Ms. Amy Mishell and
Mr. Joseph H. Mishell
Mr. Mark R. Misiorowski
Mr. and Mrs. Alan Mitchell
Ms. Ann Mohn
Mrs. Charlotte K. Monhart and
Mr. Jim Monhart
Mr. William Liang and
Mrs. Kristin N. Monsalud
Ms. Jane E. Montgomery
Mr. John Montgomery
Dr. Steven M. Montner
Mr. Jeffrey C. Moon
Mr. Eric Moore and
Mrs. Marcia Moore
Mr. William Moore
Mr. and Mrs. Willaim H. Moore IV
Mr. John Morreale
Mr. Timothy Morrin
Ms. Deborah Morris and
Dr. Stephen Morris
M. Dina Morris
Ms. Suzanne C. Morrissey and
Mr. Thomas Morrissey
Mrs. Ava Morrow and
Mr. Harold Morrow
Ms. Kitty Morton and
Mr. Ronald Morton
Mr. Bruce E. Mosbacher and
Mrs. Joan Katz Mosbacher
Ms. Frances M. Moskal
Ms. Laurie Moss
Ms. Susan T. Moss
Mr. Dennis M. Motyka and
Ms. Janice A. Motyka
Mr. and Mrs. Mark A. Moulthrop
Mr. Brian Mourning and
Ms. Jill Mourning
Mr. Jeffrey A. Mozwecz and
Ms. Monica A. Mozwecz
Mr. Daniel Mrksic
Ms. Carol Y. Mrvosh
Mr. Laurence J. Msall and
Ms. Mary J. Msall
Mr. Laurence J. Msall and
Ms. Mary J. Msall
Ms. Karla Msall and
Dr. Michael Msall
Ms. Melissa Ann Mueller
Mr. Paul R. Mueller
Ms. Mary Beth Mulcahy and
Mr. Thomas J. Mulcahy
Mr. W. A. Mulherin III
Mrs. Lori Mulhern and
Mr. Michael Mulhern
Mr. Klaus Muller-Bergh and
Mrs. Vera R. Muller-Bergh
Ms. Lou Mullins
Mr. Bruce Mumford and
Mrs. Robin Mumford
Ms. Megan Murley
Mrs. Kathleen H. Murphy and
Mr. Michael A. Murphy
Mr. James Murray
Mrs. Kristen S. Murray and
Mr. Todd A. Murray
Mr. Mark Muttilainen
Ms. Cynthia L. Mydlach
Ms. Patricia Myefski
Mrs. Janel Myers and
Mr. Kevin S. Myers
Ms. Lynn Myjak and
Mr. Robert W. Myjak
Dr. James Nachman*
Mr. Frederick J. Nachman
Mrs. Mindy Nadell and
Mr. Randy Nadell
Mr. Azim Nakhooda
Mr. Zahid Nakhooda
Mr. David N. Napalo and
Ms. Nancy Napalo
Ms. Kathleen Napolitano and
Mr. Thomas Napolitano
Mrs. Caezilie Narscius and
Dr. Kazys Narscius
Ms. Mary E. Nashert
Ms. Harriet Nathan
Mr. and Mrs. Jorde
Mitchell Nathan
Ms. Sarah Neal
Ms. Barbara A. Neece
Mr. Todd A. Needleman and
Mrs. Nancy A. Needleman
Mr. Randy Nelson and
Ms. Susan Nelson
Ms. Sharon Neste
Ms. Janet Nestrud
Mr. David Neubauer and
Mrs. Diane M. Neubauer
Mr. Josef Neulinger and
Mrs. Josef Neulinger
Mr. and Mrs. Michael Neville
Mr. Ronald Newsom
Ms. Andrea Newstead
Mr. George Nezlek
Mrs. Cathy Nichols and
Mr. Peter Nichols
Mr. Bud Nichols and
Mrs. Margaret Nichols
Mr. Richard E. Nichols
Ms. Susan T. Nichols and
Mr. Walter H. Nichols
Judith Nigro
Mr. Patrick Nimrod
Mr. Robert Nishikawa and
Dianne Peterson
Mr. Benjamin Y. Nissan
Timothy M. Nolan
Attorney at Law
Mr. James D. Nolan, Jr.
Mr. and Mrs. Timothy
Michael Nolan
North Coast Distributing, Inc.
North Suburban
Synagogue Beth El
Ms. Michelle J. Northrop
Mr. Joseph Novak and
Patricia B. Novak
Ms. Louise M. Novak and
Mr. Richard S. Novak
Mr. Brian Nowak and
Ms. Rebecca Nowak
Ms. Nancy A. Nowalk
Mr. and Mrs. Jack D. Noyes
Mr. and Mrs. David Nuelle
Mrs. Janie C. Obiala and
Mr. John R. Obiala
Mr. Phillip O’Brien
*Deceased

Dr. Bill C. O’Brien-Penney and
Ms. Noirin P. O’Brien-Penney
Mr. Joseph W. O’Connor and
Mrs. Lenore O’Connor
Ms. Monica O’Connor
Mr. and Mrs. Paul
Dennis O’Connor
Ms. Susan L. Odendahl
Cole Oehler, Jr.
Ojibwa Enterprises, Inc.
Ms. Patience A. Ojomo
Ms. Marla O’Keefe
Mr. Martin Okoro
Ms. Katelyn Olewinski
Ms. Darla Olson
Mrs. Margaret O’Neil and
Mr. Thomas O’Neil
Ms. Lisa L. O’Neill
Mr. Andrew Oppenheimer
Ms. Lauren Oppenheimer
Dr. Frederick J. Orendach
Mr. James Matthew Orlin and
Ms. Denise M. Orlin
Mr. James G. Orphan and
Mrs. Irene A. Orphan
Ms. Janet L. Orr
Mr. Jeffrey C. Orr
Mr. Julius S. Orsak, Jr. and
Mrs. Sandra G. Orsak
Mrs. Christine Ortega and
Mr. Jesus Ortega, Jr.
Ms. Francine J. Osman-Lans
Ms. Julia Osolinski
Dr. Aytekin Oto and
Mrs. Pelin Oto
Bruce and Lori Ovitz
Mrs. Barbara Owens and
Mr. Matthew J. Owens
Ms. Catherine Pabich
Mr. Peter Pacelli
Ms. Diana L. Packman
Mr. Lucio Padilla
Ms. Michal Palatnik and
Mr. Seth Palatnik
Ms. Susan Pallant
Mr. Mark Palmer
Carol C. Pankros, CFP and
Mr. Paul A. Pankros
Mrs. Deborah G. Park and
Mr. Jerry E. Park
Ms. Laurie Parker
Ms. Susan K. Parker
William B. Parker, MBA’78
Ms. Suzanne M. Parks
Mr. Jerry Parrish and
Ms. Valerie A. Parrish
Ms. Yolanda M. Pasquella
Pasquinelli Family Foundation
Mr. James Passarelli and
Mrs. Stella Passarelli
Dr. William Passodelis
Ms. Judy Pasternak
Ms. Asmita Patel
Mr. and Mrs. Brian W. Patterson
Mr. William Patterson
Dr. David M. Paushter
Ms. Judith Pavloski
Mr. Mark Pearlstein
Ms. Gail Lenore Peek and
Mr. Dean W. Chandler
Dr. Ryan Michael Peirce
Mrs. Claudia M. Pellar and
Mr. John F. Pellar
Ms. Ayla R. Pelleg
Mr. Bill Peluchiwski and
Mrs. Georgy Ann Peluchiwski
Mr. Joel T. Pelz
Ms. Caroline K. Pendell
Mrs. Frances M. Pendell and
Mr. Timothy M. Pendell
Mrs. Catherine E. Penning and
Mr. Mark S. Penning
Ms. Helen T. Pennington
Ms. Louise P. Penta
Mr. Ramon M. Perez
Mr. Christopher James Perille and
Mrs. Christine Perille
Ms. Zipporah Perlmutter
Pete Eischen Chevrolet Co.
Ms. Janice J. Peterson
Dr. Rachel L. Amdur and
Mr. Joseph Gerard Peterson
Mr. Gary A. Peterson and
Ms. Noreen M. Peterson
Mrs. Judith M. Peterson and
Mr. Thomas K. Peterson
Mr. Dennis A. Peterson and
Ms. Valerie A. Peterson
Ms. Cynthia A. Petratis
Ms. Yola T. Petrillo
Ms. Katia Petrov
Ms. Julie Pfarr and
Mr. Kenneth F. Pfarr
Mr. Boyd W. Phelps
Ms. Jean E. Phelps
Phillips Law Offices
Ms. Anna Phillips
Mr. Marion Phillips
Mr. Buddy D. Phipps
Mrs. Alice Pickford
Ms. Joni B. Pickford
Mr. and Mrs. Heber Pierce
Mr. Richard B. Pietrzak
Mr. Kurt R. Pinshower
Mr. and Mrs. John J. Piva, Jr.
Mr. John J. W. Plampin
Mrs. Irene E. Plinovich and
Mr. Michael Plinovich, Jr.
Ms. Juliet Plonsker
Ms. Renee L. Pollack
Mr. Donald R. Pollak and
Mrs. Martha W. Pollak
Mr. Andrew Pomerantz and
Mrs. Kimberly Pomerantz
Mr. Frank C. Pond
Mr. Colin Poon
Ms. Jeanne Poorman
Ms. Margaret A. Poorman and
Mr. William S. Poorman
Mrs. Dee R. Porter and
Mr. Robert M. Porter
Ms. Barbara F. Potter
Mr. James Potter and
Ms. Lelie A. Potter
Ms. Caryl S. Powell and
Mr. Robert E. Powell
Mr. Robert W. Pratt and
Ms. Catherine B. Pratt
Mr. Jonathan Prell
Mr. Richard K. Present and
Mrs. Susan W. Present
The Presidents Forum II, Inc.
Dr. Irwin Press and
Mrs. Andrea S. Press
Mr. Kyle Price
Mr. Richard A. Price
Mr. Lee J. Privoznik
Mrs. Joanne S. Prober and
Mr. Richard Prober
Pro-Type Printing
Ms. Claudette Przymanowski
Dr. Yonglin Pu and Ms. Jing Wang
Ms. Ellen Puccinelli
Mr. Jay Pudenz
Mr. Daniel G. Pufunt and
Ms. Elizabeth A. Pufunt
Ms. Patricia M. Pulsifer
Purco Heating & Air
Conditioning, Inc.
Mr. Tom Purl
Charles Pyne
Mr. Imad I. Qasim and
Mrs. Nancy Meloy Qasim
The Queenan Foundation
Ms. Diane T. Quinlan and
Mr. Willam F. Quinlan
Mr. Michael J. Quinn
Mr. Mark E. Quinnell and
Mrs. Susan S. Quinnell
Mr. Barry Quirke and
Mrs. Mary A. Quirke
Ms. Emily Rabjohns
Mrs. Kimberly Rader and
Mr. Rick Rader
Ms. Katherine Radler
Mrs. Carol Ragon and
Mr. Charles P. Ragon
Mr. Colin P. Rainier and
Ms. Karen Rainier
Dr. Michael M. Ramsey and
Dr. Ruth Ann G. Ramsey
Mrs. Anna M. Ranaldi and
Mr. Nazzareno Ranaldi
Ms. Dorothy M. Randall and
Mr. Richard L. Randall
Mr. Hugh Ravenscroft and
Ms. Lael Ravenscroft
Ms. Molly Ray
Ms. Merrilee Redmond
Ms. Pamela Reedy
Renee Rehkemper and
Jeffrey Rehkemper
Mrs. Doris J. Reid and
Mr. James C. Reid
Mr. Bradley Reiff
Mrs. Karen Reisin and
Mr. Richard Reisin
Mr. Dean Rende
Mr. Thomas B. Rentschler
Repco Sales of Georgia, Inc.
Mrs. Basia R. Retsky and
Mr. Joel Retsky
Ms. Donna Retson and
Mr. Nicholas C. Retson
Ms. Sherry Reyes
Ms. Mary Ellen Reynolds
Mr. Thomas F. Reynolds
Mr. Daniel Rhines and
Ms. Janet Lampert Rhines
Mr. Benedict Ricchio and
Mrs. Camille Ricchio
Mrs. Lynn D. Rice
Ms. Marcia Rice
Dr. Peggy Rice
Ms. Irene G. Richardson and
Mr. W. L. Richardson, Sr.
Mr. Thomas Stuart Ricketts and
Dr. Cecelia Elizabeth Ricketts
Mr. David Rietman
Mr. Donald Rigali
Mr. John Riley
Mr. Gabriel Rinconeno
Mr. Lewis Rinkerberger
Ms. Karen L. Rissler
Ms. Eunice A. Ritchie
Mr. Kenneth J. Rivard and
Linda S. Rivard
Ms. Cheryl Robbins and
Mr. Dennis Robbins
Ms. Kelcey Roberts
Ms. Kelly M. Roberts and
Mr. Thomas H. Roberts
Ms. Laura K. Roberts
Ms. Michelle C. Roberts
Ms. Allison Robertson
Ms. Lily Robinson
Ms. Paige Robinson
Dr. and Mrs. David Rochester
Mr. Thomas F. Rochford
Ms. Katharine Roever
Ms. Barbara Rogalla
Ms. Elizabeth C. Rogers
Mr. Donald Rogers and
Ms. Jacalyn Rogers
Mrs. Patricia D. Rogers and
Mr. Richard J. Rogers
Mrs. Deanne S. Roggekamp
Mr. Scott Rogoff and
Ms. Leslie Rogoff
Ms. Megan Rooney
Mr. Dennis S. Rosen and
Ms. Sandra R. Rosen
Mr. Craig Rosenberg
Mrs. Hollis Rosenberg and
Mr. Michael Rosenberg
Ms. Betsy Rosenstein and
Mr. David M. Rosenstein
Mr. Warner Rosenthal
Mr. Michael Roskin and
Ms. Ellen Roskin
Mr. William R. Rostek
Ms. Phyllis Roth
Dr. Stephen L. Roth
Mr. Gus M. Rousonelos
Mr. Edward J. Roviaro and
Mrs. Liliana N. Roviaro
Royalty Farms, LLC
Mr. Roy Rozgo
Mr. Blanche Rozner
Ms. Kathryn E. Rozum
RSM McGladrey
Ms. Tamara Ruben
Mr. Earl E. Rubinoff and
Ms. Rochelle D. Rubinoff
Ms. Betsy E. Rubinstein
Ms. Kris Rucinki
Mr. Lionel E. Bolin and
Ms. Jean Rudd
Ms. Beatrice Rudisch
Mr. William Alan Rudnick and
Ms. Lisa Luise Walker
Mrs. Howard Rudolf
Mr. David Rueff and
Ms. Phyllis Rueff
Mrs. Dorothy A. Ruhl
Mrs. Anne Marie Russell and
Mr. Michael Russell
Mr. Daniel K. Ryan and
Mrs. Julie Wise Ryan
Ms. Mary R. Ryan and
Mr. Richard R. Ryan
Ms. Beth G. Rybakowicz
Mr. Paul Sabin
Mr. Richard Sabol
Dr. and Mrs. Ahmad Sadeghi
Ms. Lisa Sagami
Mr. James L. Sagarin and
Mrs. Lori B. Sagarin
Mrs. Kathryn Saitelbach and
Mr. Steven Saitelbach
Mr. Irwin Saltz and
Mrs. Janice Saltz
2011–2012 donors
61

Ms. Alison Salzman and
Mr. Martin W. Salzman
Mr. Bernard B. Salzman and
Mrs. Janice G. Salzman
Mrs. Julie A. Samson and
Mr. Robert J. Samson
Samuel Weinstein
Family Foundation
Mrs. Mary T. Samuel
Ms. Deborah R. Samuels
Sand Creek Country Club
Regina Sandberg
Mr. Calvin Sanders, Jr.
Mr. Keith W. Sanders and
Ms. Metta K. Sanders
Ms. Terri A. Sandlin
Ms. Beth Sandon
Ms. Bethany A. Sandon
Ms. Dorothy Santolino
Ms. Hilary Sargent
Ms. Elizabeth Sattelberger
Michael B. Satz and
Patricia A. Satz
Mrs. Julie G. Savastio and
Mr. Ray Savastio
Mr. Abraham Sayegh and
Mrs. Amy G. Sayegh
Ms. Sally Schaeffer
Mr. Peter Harris Schaff and
Ms. Alice Schaff
Mr. Miguel Saps Kranzenblum
and Gilda Schaffer, PsyD
Ms. P.J. Schaffer
Mr. Robert P. Schaible
Mrs. Bridget M. Scharpenberg
and Mr. Jeremy P. Scharpenberg
Mr. Daniel Schecter and
Mrs. Jill Schecter
Mr. Arthur R. Scheierman and
Mrs. Carol J. Scheierman
Mr. Edgar D. Scherer and
Ms. Lisa K. Scherer
Mr. David R. Schiemann and
Mrs. Margaret R. Schiemann
Schiffer Publishing, Ltd.
Mr. David M. Schiffman and
Ms. Judith Feigon Schiffman
Mrs. Pamela S. Schindler and
Mr. William Schindler
Mr. David L. Schlitter and
Ms. Sharon Schlitter
Mr. and Mrs. Robert L.
Schlossberg
Ms. Sally J. Schmehl
Ms. Mary Marcelite Schmick
Mr. Fred Schmid
Ms. Nancy L. Schmid
Mr. Allan Schmidt
Mr. Daniel L. Schmidt
Ms. Paula Schmidt
Mr. William A. Schmidt
Mr. and Mrs. Frank Schmitz
Mr. Mark Schnitzer
Mr. Paul Schoenwetter
Mr. Ed L. Schotz
Ms. Lynn S. Schrayer and
Mr. Max R. Schrayer
Mr. Jack Schriver and
Mrs. Pamela Schriver
Mr. Alexander Schubow
Ms. Mary B. Schultz
Mrs. Cathy Schulze Coll
Dr. James Schwade
Mr. and Mrs. David R. Schwartz
Mrs. Deborah Matek Schwartz
and Mr. Lee Schwartz
Mrs. Peggy Schwartz
Mr. and Mrs. Richard D. Schwartz
Ms. Terry Schwartz
Mr. William Scorzo
Ms. Kelly Scotti
Mr. Dennis K. Scully
Mrs. Richard P. Scully
Ms. Cheryl Seder
Mr. and Mrs. Stephen P. Seder
Ms. Verne P. Seehausen
Ms. Marguerite Seeley
Mr. Thomas McKean Seftenberg
and Ms. Lee Margaret Seftenberg
Mr. Jose P. Segovia
Ms. Gail Seidel-O’Gorman
Ms. Nicole J. Seidlitz
Mr. Warren Seigel
Mr. H. D. Selbst and
Mrs. Susan H. Selbst
Ms. Carmel Barbara Sella
Ms. Nalini D. Selvaraj
Mr. Frank Sennett
Mr. Louis A. Seno
Stephen A. Serck and
Michelle Serck
Mitchell I. Serota, PhD, and
Mrs. Barbara W. Serota
Mr. and Mrs. Harold Shabelman
Mr. Robert M. Shafton
Mr. and Mrs. Edwin H. Shanberg
Mr. Brad Shapiro
Ms. Kate Shapiro
Mr. Bruce Sharp
Ms. Catherine M. Shaw
Mr. Gregory S. Shearson and
Mrs. Mary R. Shearson
Mr. Douglas J. Sheehy and
Ms. Lorraine A. Sheehy
Mr. Michael D. Sher and
Ms. Sara R. Sher
Mrs. Janet Sherfrey and
Mr. Jerry Sherfrey
Ms. Barbara Sherman and
Mr. Darin K. Sherman
Mr. Jeffrey W. Sherman and
Mrs. Mary B. Sherman
Mr. Bruce Sherman and
Mrs. Laura D. Sherman
Ms. Wendy C. Sherman
Ms. Leslie Shoemaker
Mr. and Mrs. Lloyd G. Shore
Shoshana Friedman
Revocable Trust
Ms. Sherrill Sibley and
Mr. W. Tim Sibley
Siegel Decorating Company
Mr. Anthony J. Siegel
Ms. Susan Bandes and
Mr. Stephen Siegel
Ms. Susan Siegel
Ilse Siegler
Mr. Mark B. Sielaff
Mr. and Mrs. Jerry G. Silbert
Mr. Joshua Silvers and
Mrs. Kathryn Silvers
Mr. Adam Simon
Mr. Barry S. Marx and
Ms. Allyn L. Simon
Mr. Gregory Mark Shade and
Ms. Linda J. Simon
Mr. Sean Simons
Ms. Karen Simpson
Mr. Richard Sincere
Christine Singer and Paul Singer
Mr. James I. Singer and
Mrs. Janet K. Singer
Ms. Miriam Rogers Singer
Dr. Jaideep K. Singh and
Mr. Kuldeep Singh
Ms. Jackie H. Singleton
Mr. James J. Sisul
Mr. Arif Sitabkha
Mrs. Laren D. Siwinski and
Mr. Steven Siwinski
Mr. Ben Skaggs
Mrs. Kathy R. Skelton and
Mr. Michael E. Skelton
Mr. and Mrs. Gus P. Skizas
Ms. Bari Slack
Mrs. Carrie W. Smart and
Mr. John R. Smart
Smith, Dukes & Buckalew, LLP
Ms. Anne R. Smith
Mr. Elmer Smith
Ms. Kathryn Smith
Ms. Kristin Smith
Ms. Kristina Smith
Ms. Laura Smith
Ms. Patricia A. Smith and
Mr. William J. Smith
Mr. Phillip Smith
Dr. Ralph H. Smith, Jr.
Mr. Roff W. Smith and
Mrs. Sally A. Smith
Ms. Barbara Snidanko
Mr. Rowe Winston Snider and
Mrs. Susan C. Snider
Mr. Donald J. Snow and
Mrs. Patricia C. Snow
Ms. Carol A. Snow and
Mr. Ronald A. Snow
Ms. Jocelyn E. Snower and
Mr. Steven M. Snower
Mr. Brian Snyder and
Mrs. Tamara Snyder
Ms. Dolores R. Soich
Mr. Jonothan D. Sokoloff and
Ms. Sheryl D. Sokoloff
Mr. Jim Soldan
Mr. and Mrs. Leonard H. Solomon
Mrs. Darla J. Sorenson and
Mr. Paul G. Sorenson
Ms. Deanna Soucie and
Mr. Gregory Soucie
Ms. Karen M. Sparks and
Mr. Ralph D. Sparks
Ms. Jean E. Spence
Mr. Barry L. Spicer and
Mrs. Sharon K. Spicer
Ms. Julie Spiezio
St. Mary Immaculate Parish
Mr. Daniel Stacey and
Mrs. Mary Stacey
Dr. Gregory S. Stacy and
Mrs. Andrea Stacy
David J. Stagman and
Allison Margolies
Mr. Fred Stambaugh and
Ms. Virginia Stambaugh
Ms. Paula K. Stamos
Mr. Brad Stanis and
Ms. Kerry Stanis
Ms. Allyson Stark
Ms. Dianne M. Stark
Mr. Arkadiy Starobin
Ms. Shawna Stassen
Dr. Mindy B. Statter
The Stauber Family Foundation
Mr. Chris S. Stegh and
Mrs. Kelly S. Stegh
Mr. Mark H. Stein
Dr. Donald F. Steiner
Mr. Richard P. Steinken and
Ms. Therese M. Steinken
Mr. David Stender and
Ms. Amy Stender
Mr. Sergey Stepanov
Ms. Caitlin Stephens
Ms. Rosalind Stephens
Mr. Al Stephenson and
Mrs. Barbara Stephenson
Mrs. Barbara A. Stern and
Mr. Harold J. Stern
Ms. Marlene E. Stern
Mr. David Sternberg and
Mrs. Eydie L. Sternberg
Ms. Kate Sternberg
Mr. Gary R. Stevens and
Ms. JoAnn Stevens
Mr. James P. Stevens
Mr. Ray Stickler
Professor Carolyn Stieber
Mr. Douglas J. Srieber and
Mrs. Melanie Stieber
Mr. Andrew Stimson
Ms. Jennifer Stix
Ms. Heather Stoddard
Mr. Mark Stoermer
Ms. Julie E. Stogsdill
Mr. Gary David Strandlund
Dr. Christopher M. Straus
Dr. and Mrs. Bernard S. Strauss
Ms. Kimberly Strauss
Mr. John L. Street
Mr. Douglas A. Strubel and
Ms. Meghan T. Strubel
Mr. Richard W. Stuckert and
Mrs. Susan H. Stuckert
Mr. Richard Sturm
Styliades Hellenic
Orthodox Foundation
Mr. Nilesh Sudrania
Ms. Catherine Sullivan
Mr. Joseph J. Sullivan and
Mrs. Julie J. Sullivan
Ms. Kathleen A. Sullivan
Mr. Michael Sullivan
Ms. Michele H. Sullivan
Mr. Thomas J. Sullivan
Mr. Daniel C. Sussen
Dr. and Mrs. Mitchell Sussman
Ms. Lisa Suter
Ms. Dee Sutphin
Mr. Roger Swanson
Ms. Diane M. Swayne
Mr. Anthony J. Swenson and
Mrs. Courtney S. Swenson
Ms. Eileen K. Swikle and
Mr. Randy G. Swikle
Mrs. Olga Swiontek
Ms. Marilyn Swoiskin
Mr. Hashim Syed
Syracuse University
Ms. Linda Tammen
Mr. and Mrs. Chung-Liang Tang
Ms. Donna J. Tarnowski
Ms. Dolores Tata
Mr. and Mrs. James S. Tauber
Mrs. Beth A. Taussig
Ms. Gloria Taussig
Ms. Marianne K. Taussig and
Mr. Stuart K. Taussig
Ms. Kimberly S. Taylor
Mr. Rusty Taylor
Mr. and Mrs. Earl H. Temkin
Ms. Vicki Temkin
Mrs. Cynthia A. Tenczar and
Mr. Keith A. Tenczar

Ms. Ann Tenzillo
Ms. Charlene M. Terlizzi
Ms. Maria Thalheimer
Mrs. Aline Thalheimer and
Mr. Roland Thalheimer
Mr. John P. Thallemer
The Kuntz Foundation
The Robert and Beverly Lewis
Family Foundation
The Unique Educational
Society, Inc.
Mr. Lowell M. Thomas
Mr. Stephen Thomas
Mr. Walter Thomas
Mr. Gabriel James Thompson
Jennifer Thompson
Mr. David R. Thornbury and
Mrs. Judith A. Thornbury
Ms. Jean Tibbetts
Mr. John R. Tieman and
Mrs. Peggy M. Tieman
Tieri Family Fund
Ms. Mary L. Tieri
Mr. and Mrs. Glenn R. Tilles
Ms. Christine Tiseo
Tix 4 Causes, LLC
Mr. David Tobin and
Ms. Kelley Tobin
Ms. Gergana Todorova
Mr. Donald Toma and
Mrs. Janice Toma
Mr. Andrew Tomka
Ms. Joyce M. Topolski
Mr. Lupe Torres and
Ms. Stella Torres
Mr. John K. Totten and
Mrs. Mary T. Totten
Ms. Ariel S. Towers
Mr. William Towle
Mr. and Mrs. Simon Trachtenberg
Ms. Traci L. Trapp
Mr. Friedrich Tremmel and
Mrs. Lynn Tremmel
Ms. Angela Trotter
Ms. Pamela Troy
Mr. Danny L. Trueblood and
Ms. Monica Trueblood
Truist
Mr. John McNamara and
Ms. Robin S. Tryloff
Ms. Andrea E. Tsakopoulos and
Mr. Tom J. Tsakopoulos
Ms. Carmen G. Tumino
Mr. Harry Tunnell
Mr. Wayne S. Turczi
Dr. David A. Turner and
Mrs. Bonita C. Turner
Dr. James Turner and
Ms. Julianne Christine Turner
Mr. John L. Turner and
Ms. Suzanne H. Turner
Ms. Lori Twombly
Mr. and Mrs. Timothy H. Ubben
Dr. Eric J. Udoff and
Ms. Ronni C. Udoff
In Honor of Gifts Unattributed
Memorial Gifts Unattributed
Mr. Josef Unhold
Mr. David Ureel
V. C. M. Sales, Inc.
Ms. Debora M. Van Tuyle
Ms. Jane Van Tuyle
Ms. Karen Van Tuyle
Ms. Stephanie Van Winkle
Ms. Catherine Vanden Boom
Frances Vandervoort,
CER’82, SB’57, SM’65 and
Peter Vandervoort, AB’54,
SB’55, SM’56, PHD’60
Mr. Ron Vari
Mr. Bryan H. Veatch and
Mrs. Kathleen L. Veatch
Mr. Gary A. Verhoeven and
Ms. Alice Williams-Verhoeven
Mrs. Carolynne R. Vermiglio and
Mr. Joseph V. Vermiglio
Ms. Deborah L. Vervack
Mr. Alexander S. Vesselinovitch
and Mrs. Joan I. Vesselinovitch
Vestergaard Consulting, Ltd.
Ms. Ellen Vesterguaard
Mr. Daniel Vida
Ms. Terrie L. Von Lowe
Ms. Diane Von Schnase
Mr. Edward F. Vonesh, Jr.
Mr. and Mrs. Robert Von Halle
Ms. Cheryl A. Vopinek
Ms. Nina Waack
Ms. Amanda Wade
Mr. Burnell Wade
Mr. Roger D. Wagner and
Ms. Sally A. Wagner
Ms. Susan K. Wagner
Wahl Clipper Corporation
Ms. Jeanne Wakenight
Mr. Daniel Wald and
Ms. Andrea Wald
Mr. Peter S. Walker and
Mrs. Vicki L. Walker
Mr. and Mrs. Alan M. Wallis
Mr. Donald J. Walsh and
Mrs. Jacqueline A. Walsh
Ms. Mary L. Walsh
Mrs. Ruth Ann Freedman and
Mr. Daniel J. Wander
Mr. Richard A. Wang
Mrs. Diane X. Liu and
Mr. Sheglin Wang
Mr. Jimmie Lou Ward
Mrs. Loree L. Wasserman and
Mr. Robert J. Wasserman
Ms. Joy Wates Cox
Ms. Marci J. Webb
Mr. Ronald Weber and
Mrs. Alysa Weber
Ms. Margaret J. Weber and
Mr. William M. Weber
Ms. Margaret Weeks
Mrs. Marjorie K. Wegener and
Mr. Mark A. Wegener
Mr. Victor Weihler
Mr. James Weiler
Mrs. Doris L. Weinbaum and
Mr. Michael A. Weinbaum
Mr. and Mrs. Michael Weinger
Ms. Lottie W. Weinstein
Mr. Samuel Weinstein
Mrs. Lise Weisberger
Ms. Stephanie Weiser
Mr. Edgar R. Weiss and
Mrs. Marlene J. Weiss
Dr. Karen Weiss
Rabbi Victor H. Weissberg,
DHL, DD
Mr. Richard Paul Welcome and
Ms. Marcia Welcome
Wells Fargo Insurance Services
Mr. Charles L. Welter
Mrs. Virginia R. Wendt
Ms. Stephanie Werner
Mr. Thomas Wernimont
Ms. Marilyn B. Barnett and
Dr. Barnett C. Wesley
West Suburban Imaging
Associates, S.C.
Ms. Audrey L. West
Mr. Henry J. West and
Ms. Georgia West
Mr. Steven West
Ms. Karen L. Westbrook and
Mr. Robert W. Westbrook
Mr. and Mrs. Mark Westcott
Mr. Jack C. Wetzel
Mr. Richard L. Wexler and
Mrs. Roberta Wexler
Ms. Rachel E. Whalen
Ms. Judith Whisler
Mr. Richard Ashley White and
Ms. Joan P. White
Ms. Kathy Whitt
Mr. Edward E. Wicks and
Mrs. Maralee Sabath Wicks
Mr. Eugene J. Wilczynski and
Mrs. Mary Ann Wilczynski
Ms. Lindsay Wilde
Ms. Mary Ann Wilhelmi
Mrs. Brenda S. Wilken and
Mr. Mack D. Wilken
Mr. and Mrs. James R. Willhoite
Mrs. Elizabeth T. Williams
Ms. Lorry L. Williams
Ms. Carrie Williams-George
Ms. Sally K. Willis
Ms. Cynthia Wills and
Mr. Dale Wills
Mr. Charles R. Wilt
Mr. Steven Winarski
Dr. and Mrs. Jerome A. Winer
Mrs. Felicia F. Winiecki and
Mr. Kurt Winiecki
Ms. Jennifer J. Wirth
Ms. Catherine M. Wirtz
Ms. Audrey Wisel
Ms. Cynthia A. Witowski
Mr. Oliver Witte
Ms. Iris Wittenberg
Ms. Hayley J. Witwer
Mr. Jeffrey K. Wohlstadter
Mrs. Radyne P. Wolf and
Dr. Steven L. Wolf
Wolfe Beverage Company, Inc.
Mr. Jay R. Wolff and
Mrs. Jay R. Wolff
Mrs. Karel L. Wolfson
Mr. Charles Wollensak
Ms. Stanislawa Wolski
Mr. Thomas H. Woo
Ms. Abigail Wood
Mr. Barry Wood and
Mrs. Marcia Wood
Mr. Mark Wood and
Mrs. Mary P. Wood
Ms. Terri Woodbury
Woodland Farm, Ltd.
Ms. Emily Woodrow
Dr. William G. Woods
Ms. Jane H. Woodward and
Mr. L. H. Woodward
Mr. Robert E. Wooldridge and
Carol R. Wooldridge
Mr. Chester Wright
Samuel G. Armato III, PhD, and
Mrs. Suzanne M. Wrobel Armato
Y. Dehrey & S. Forer-Dehrey
Family Trust
Ms. Sharon Yagoda
Mr. Edward Yang
Mr. Paul N. Yannias and
Ms. Cynthia A. Yannias
Mrs. Gwen Sommers Yant and
Mr. Richard D. Yant
Ms. Eileen Yedlin
Mrs. Delores Yenerich and
Mr. Paul Yenerich
Mr. and Mrs. William C.
Youngberg
Dr. Yulei Jiang and Ms. Ching Yue
Mr. Karim Yunez
Ms. Nancy S. Zabrin and
Mr. Stephen B. Zabrin
Ms. Jessica L. Zacharski
Dr. and Mrs. Lawrence Zachary
Ms. Cindy Zallik and
Mr. Ned I. Zallik
Dr. Tracie Wilcox and
Dr. Steven M. Zangan
Ms. Silvia Frajberg and
Dr. Mario Zaritzky
Mr. Ian Zawacki
Mr. Eugene Zell and
Ms. Merrie E. Zell
Mrs. Carol A. Zeng and
Mr. John H. Zeng
Mr. Ryan Zentz and
Mrs. Teresa Zentz
Mr. Liu Zhang
Mr. Guangchang Zhou
Mrs. Barbara J. Zick and
Mr. Jeffrey V. Zick
Mr. Gregory Zick and
Mrs. Rachel I. Zick
Ms. Amy Zimmerman
Mr. Frank Zimmerman
Ms. Sarah O. Zimmerman
Mr. and Mrs. William Zimmerman
Mr. Eilliott Zirlin
Mr. and Mrs. Jerrold R. Zisook
Mr. and Mrs. Edmond Zisook
Mr. Harry Zoberman and
Mrs. Lily Zoberman
Mr. George Zoellick
Ms. Ronna Zoll
William Zolla, JD’65
Mr. Elliot Zorensky and
Mrs. Jodi Zorensky
Ms. Robertas Zukauskas
Mr. Michael A. Zuraw and
Mrs. Susan E. Zuraw
Ms. Shelley E. Zuraw
Mr. Daniel Zurawski
2011–2012 donors
63

Courtesy of Rafael Vinoly Architects, copyright Thomas Rossiter

the university
of chicago
medicine
comprehensive
cancer center
66

leadership
credits
Michelle M. Le Beau, PhD
Director, UCCCC; Arthur and Marian Edelstein Professor
of Medicine; Director, Cancer Cytogenetics Laboratory
Marcy A. List, PhD
Associate Director for Administration, UCCCC;
Scientific Director, Cancer Clinical Trials Office
Marsha R. Rosner, PhD
Deputy Director for Basic Sciences, UCCCC;
Charles B. Huggins Professor and Chair, Ben May
Department for Cancer Research
Richard L. Schilsky, MD
Deputy Director for Clinical Sciences, UCCCC; Professor
of Medicine; Section Chief, Hematology/Oncology
Habibul Ahsan, MBBS, MMedSc
Associate Director for Population Research, UCCCC;
Louis Block Professor of Health Studies, Medicine,
and Human Genetics
Geoffrey L. Greene, PhD
Associate Director for Basic Sciences and Education,
UCCCC; Virginia and D.K. Ludwig Professor and
Vice Chair, Ben May Department for Cancer Research;
Co-Director, Ludwig Center for Metastasis Research
Mark Ratain, MD
Associate Director for Clinical Sciences, UCCCC;
Leon O. Jacobson Professor of Medicine; Director,
Center for Personalized Therapeutics
Ravi Salgia, MD, PhD
Associate Director for Translational Sciences;
Professor of Medicine; Director, Thoracic Oncology
Ezra Cohen, MD
Associate Director for Education;
Associate Professor of Medicine
Karen E. Kim, MD, MS
Director, UCCCC Office of Community Engagement
and Cancer Disparities; Professor of Medicine
James Schilling, PhD
Associate Director for Core Facilities, UCCCC;
Director, Office of Shared Research Facilities
Mary Ellen Connellan, MA
Executive Director, The University of Chicago Cancer
Research Foundation
Rajan Gopalakrishnan, MS
Director, Informatics and Information Technology
Hoyee Leong, PhD
Director, Scientific Communications and
Strategic Partnerships
Christine Miller, MA
Director, Finance
Sumati Murli, PhD
Director, Clinical Research Operations;
Technical Director, Cancer Clinical Trials Office
Executive Editor
Hoyee Leong, PhD
Assistant Editor
Jane Kollmer
Contributing Writers
Cassie Simon, CTR
Design
Pivot Design, Inc., Chicago, Illinois
Printing
G Thomas Partners LLC, Lemont, Illinois
Photography
Serena Dawn Boggs
David Christopher
For More Information
+1 773 702 6180
cancer.uchicago.edu
67

5841 S. Maryland Avenue, MC 1140
Chicago, IL 60637-1470
cancer.uchicago.edu